Alberto Zanchetti

Q: What Schools Are Affiliated With Alberto Zanchetti

Alberto Zanchetti is affiliated with the following schools: Medical University of Vienna, Consorzio ICoN, University of Milan, Virginia Commonwealth University, Michigan State University, University of Milano-Bicocca

Alberto Zanchetti's AcademicInfluence.com Rankings

Alberto Zanchetti

Medical

#615

World Rank

#821

Historical Rank

Cardiology

#24

World Rank

#24

Historical Rank

medical Degrees

Alberto Zanchetti

Engineering

#1508

World Rank

#2210

Historical Rank

Cybernetics

#18

World Rank

#21

Historical Rank

Biomedical Engineering

#29

World Rank

#29

Historical Rank

engineering Degrees

Download Badge

Medical
Engineering

Why Is Alberto Zanchetti Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Alberto Zanchetti's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) (2007) (9420)
2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). (2013) (6036)
Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial (1998) (5865)
2018 ESC/ESH Guidelines for the management of arterial hypertension. (2018) (5481)
2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). (2007) (5476)
2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). (2007) (3077)
Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension (1997) (2671)
2003 European Society of Hypertension-European Society of Cardiology Guidelines for the Management of Arterial Hypertension (2003) (2640)
[2018 ESC/ESH Guidelines for the management of arterial hypertension]. (2019) (2445)
Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial (2004) (2115)
2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. (2007) (1965)
Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. (2009) (1857)
[2018 ESC/ESH Guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH)]. (2018) (1684)
Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document (2009) (1452)
The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial (2003) (1433)
European Society of Hypertension position paper on ambulatory blood pressure monitoring. (2013) (1184)
2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC Task Force for the Management of Arterial Hypertension. (2013) (1115)
The task force for the management ofarterial hypertension of the european society ofhypertension (esh) and of the european society of cardiology (esc) (2013) (991)
2007 ESH‐ESC Guidelines for the management of arterial hypertension (2007) (921)
European Society of Hypertension guidelines for blood pressure monitoring at home: a summary report of the Second International Consensus Conference on Home Blood Pressure Monitoring (2008) (823)
The 2013 ESH/ESC guidelines for the management of arterial hypertension (2013) (805)
Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. (1997) (797)
Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials (2012) (761)
2013 ESH/ESC Guidelines for the management of arterial hypertension (2013) (754)
European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring. (2014) (731)
Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial. (2003) (723)
EFFECTS OF BLOOD-PRESSURE MEASUREMENT BY THE DOCTOR ON PATIENT'S BLOOD PRESSURE AND HEART RATE (1983) (709)
Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. (2009) (707)
Blood pressure dependent and independent effects of antihypertensive treatment on clinical events in the VALUE Trial (2004) (612)
Ambulatory blood pressure normality: results from the PAMELA study (1995) (611)
Evaluation of the Baroreceptor‐Heart Rate Reflex by 24‐Hour Intra‐arterial Blood Pressure Monitoring in Humans (1988) (599)
2013 ESH/ESC Practice Guidelines for the Management of Arterial Hypertension (2014) (579)
A European Society of Cardiology survey of secondary prevention of coronary heart disease: Principal results. (1997) (578)
Ambulatory Blood Pressure Is Superior to Clinic Blood Pressure in Predicting Treatment-Induced Regression of Left Ventricular Hypertrophy (1997) (566)
2016 European Society of Hypertension guidelines for the management of high blood pressure in children and adolescents. (2016) (544)
Calcium Antagonist Lacidipine Slows Down Progression of Asymptomatic Carotid Atherosclerosis: Principal Results of the European Lacidipine Study on Atherosclerosis (ELSA), a Randomized, Double-Blind, Long-Term Trial (2002) (528)
Management of high blood pressure in children and adolescents: recommendations of the European Society of Hypertension. (2009) (528)
Alterations of Cardiac Structure in Patients With Isolated Office, Ambulatory, or Home Hypertension: Data From the General Population (Pressione Arteriose Monitorate E Loro Associazioni [PAMELA] Study) (2001) (527)
A sympathetic reflex elicited by experimental coronary occlusion. (1969) (522)
Renal function and intensive lowering of blood pressure in hypertensive participants of the hypertension optimal treatment (HOT) study. (2001) (499)
Alerting reaction and rise in blood pressure during measurement by physician and nurse. (1987) (489)
2018 Practice Guidelines for the management of arterial hypertension of the European Society of Hypertension and the European Society of Cardiology: ESH/ESC Task Force for the Management of Arterial Hypertension. (2018) (476)
European Society of Hypertension Practice Guidelines for home blood pressure monitoring (2010) (465)
The Felodipine Event Reduction (FEVER) Study: a randomized long-term placebo-controlled trial in Chinese hypertensive patients (2005) (376)
Practice guidelines for primary care physicians: 2003 ESH/ESC hypertension guidelines. (2003) (368)
1993 Guidelines for the Management of Mild Hypertension: Memorandum From a World Health Organization/ International Society of Hypertension Meeting (1993) (348)
Blood pressure-dependent and independent effects of agents that inhibit the renin–angiotensin system (2007) (314)
Blood-pressure control in the hypertensive population (1997) (314)
When should antihypertensive drug treatment be initiated and to what levels should systolic blood pressure be lowered? A critical reappraisal (2009) (309)
Risk factors associated with alterations in carotid intima—media thickness in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis (1998) (308)
Relation between blood pressure variability and carotid artery damage in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis (ELSA) (2001) (301)
High prevalence of cardiac and extracardiac target organ damage in refractory hypertension (2001) (297)
The Verapamil in Hypertension and Atherosclerosis Study (VHAS): Results of long‐term randomized treatment with either verapamil or chlorthalidone on carotid intima‐media thickness (1998) (288)
New-onset diabetes and antihypertensive drugs. (2006) (287)
Genome-Wide Association Study of Blood Pressure Extremes Identifies Variant near UMOD Associated with Hypertension (2010) (285)
[Management of high blood pressure in children and adolescents: Recommendations of the European Society of hypertension]. (2010) (284)
Effects of blood pressure lowering on outcome incidence in hypertension. 1. Overview, meta-analyses, and meta-regression analyses of randomized trials (2014) (257)
2018 Practice guidelines for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension (2018) (254)
Effects of blood pressure lowering on outcome incidence in hypertension: 7. Effects of more vs. less intensive blood pressure lowering and different achieved blood pressure levels – updated overview and meta-analyses of randomized trials (2016) (253)
Ambulatory blood pressure is superior to clinic blood pressure in predicting treatment-induced regression of left ventricular hypertrophy. SAMPLE Study Group. Study on Ambulatory Monitoring of Blood Pressure and Lisinopril Evaluation. (1997) (234)
Metabolic Syndrome in the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) Study: Daily Life Blood Pressure, Cardiac Damage, and Prognosis (2007) (226)
Reduced incidence of new-onset atrial fibrillation with angiotensin II receptor blockade: the VALUE trial (2008) (224)
Functional role of renal afferents. (1991) (223)
Identification and management of the hypertensive patient with elevated heart rate: statement of a European Society of Hypertension Consensus Meeting. (2006) (223)
Baseline Characteristics and Early Blood Pressure Control in the CONVINCE Trial (2001) (218)
Stroke prevention with the angiotensin II type 1-receptor blocker candesartan in elderly patients with isolated systolic hypertension: the Study on Cognition and Prognosis in the Elderly (SCOPE). (2004) (211)
Role of echocardiography and carotid ultrasonography in stratifying risk in patients with essential hypertension: the Assessment of Prognostic Risk Observational Survey (2002) (206)
Effects of blood pressure lowering on outcome incidence in hypertension: 4. Effects of various classes of antihypertensive drugs – Overview and meta-analyses (2015) (206)
The effect of vagal afferent stimulation on the EEG pattern of the cat. (1952) (205)
Cardiovascular target organ damage in essential hypertensives with or without reproducible nocturnal fall in blood pressure (2004) (205)
Seasonal variations in home and ambulatory blood pressure in the PAMELA population (1998) (204)
Study on COgnition and Prognosis in the Elderly (SCOPE). (2000) (204)
The effects of blood pressure reduction and of different blood pressure-lowering regimens on major cardiovascular events according to baseline blood pressure: meta-analysis of randomized trials (2011) (203)
Effects of immediate versus delayed antihypertensive therapy on outcome in the Systolic Hypertension in Europe Trial (2004) (201)
Metabolic syndrome and target organ damage in untreated essential hypertensives (2004) (197)
Guidelines for the use of self-blood pressure monitoring: a summary report of the First International Consensus Conference. Groupe Evaluation & Measure of the French Society of Hypertension. (2000) (195)
International Society of Hypertension (ISH): statement on the management of blood pressure in acute stroke. (2003) (191)
Effects of telmisartan, irbesartan, valsartan, candesartan, and losartan on cancers in 15 trials enrolling 138 769 individuals (2011) (189)
Ambulatory and home blood pressure normality in the elderly: data from the PAMELA population. (1997) (184)
Prevention of Sudden Cardiac Death After a First Myocardial Infarction by Pharmacologic or Surgical Antiadrenergic Interventions (1992) (181)
Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis (2021) (181)
Target organ damage and non-dipping pattern defined by two sessions of ambulatory blood pressure monitoring in recently diagnosed essential hypertensive patients (2001) (180)
Comparison of cardiovascular, renal, and humoral effects of acute administration of two calcium channel blockers in normotensive and hypertensive subjects. (1982) (173)
Baroreflex sensitivity and its evolution during the first year after myocardial infarction. (1988) (172)
Baseline reproducibility of B‐mode ultrasonic measurement of carotid artery intima – media thickness: the European Lacidipine Study on Atherosclerosis (ELSA) (2000) (170)
Effects of Quercetin on Blood Pressure: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials (2016) (170)
Effects of blood-pressure-lowering treatment on outcome incidence in hypertension: 10 – Should blood pressure management differ in hypertensive patients with and without diabetes mellitus? Overview and meta-analyses of randomized trials (2017) (167)
Aspirin is beneficial in hypertensive patients with chronic kidney disease: a post-hoc subgroup analysis of a randomized controlled trial. (2010) (166)
Effects of valsartan compared to amlodipine on preventing type 2 diabetes in high-risk hypertensive patients: the VALUE trial (2006) (165)
Outcomes in subgroups of hypertensive patients treated with regimens based on valsartan and amlodipine: an analysis of findings from the VALUE trial (2006) (165)
The 1993 guidelines for the management of mild hypertension: memorandum from a WHO/ISH meeting. (1993) (165)
Neural mechanisms in life-threatening arrhythmias. (1980) (162)
Effects of individual risk factors on the incidence of cardiovascular events in the treated hypertensive patients of the Hypertension Optimal Treatment Study. HOT Study Group. (2001) (160)
Effects of blood pressure lowering on outcome incidence in hypertension: 2. Effects at different baseline and achieved blood pressure levels – overview and meta-analyses of randomized trials (2014) (160)
Different Effects of Antihypertensive Therapies Based on Losartan or Atenolol on Ultrasound and Biochemical Markers of Myocardial Fibrosis: Results of a Randomized Trial (2004) (159)
Menopause-related blood pressure increase and its relationship to age and body mass index: the SIMONA epidemiological study (2005) (155)
Different Effects of Antihypertensive Regimens Based on Fosinopril or Hydrochlorothiazide With or Without Lipid Lowering by Pravastatin on Progression of Asymptomatic Carotid Atherosclerosis: Principal Results of PHYLLIS—A Randomized Double-Blind Trial (2004) (154)
Antihypertensive treatment in patients with type-2 diabetes mellitus: what guidance from recent controlled randomized trials? (2002) (154)
1993 guidelines for the management of mild hypertension: memorandum from a WHO/ISH meeting. (1993) (152)
Low glomerular filtration in the population: prevalence, associated disorders, and awareness. (2006) (152)
Subgroup and per-protocol analysis of the randomized European Trial on Isolated Systolic Hypertension in the Elderly. (1998) (149)
White-coat hypertension: misnomers, misconceptions and misunderstandings. What should we do next? (1996) (149)
The Valsartan Antihypertensive Long-Term Use Evaluation (VALUE) Trial: Outcomes in Patients Receiving Monotherapy (2006) (148)
The variable-pressure neck-chamber method for studying the carotid baroreflex in man. (1977) (146)
Association Between More Intensive vs Less Intensive Blood Pressure Lowering and Risk of Mortality in Chronic Kidney Disease Stages 3 to 5: A Systematic Review and Meta-analysis (2017) (139)
Lack of placebo effect on ambulatory blood pressure. (1995) (137)
Autonomic hypothalamic outbursts elicited by cerebellar stimulation. (1954) (135)
Circulatory reflexes from carotid and extracarotid baroreceptor areas in man. (1977) (134)
Effects of losartan and atenolol on left ventricular mass and neurohormonal profile in patients with essential hypertension and left ventricular hypertrophy (2002) (134)
Effect of baseline cognitive function and antihypertensive treatment on cognitive and cardiovascular outcomes: Study on COgnition and Prognosis in the Elderly (SCOPE) (2005) (133)
Benefits and risks of more intensive blood pressure lowering in hypertensive patients of the HOT study with different risk profiles: does a J-shaped curve exist in smokers? (2003) (133)
Blood pressure control in Italy: results of recent surveys on hypertension (2007) (133)
Presistent patterns of wakefulness in the pretrigeminal midpontine preparation. (1958) (133)
Methodology and technology for peripheral and central blood pressure and blood pressure variability measurement: current status and future directions – Position statement of the European Society of Hypertension Working Group on blood pressure monitoring and cardiovascular variability (2016) (132)
Hypotensive and renin-suppressing activities of propranolol in hypertensive patients. (1975) (128)
Is a systolic blood pressure target <140 mmHg indicated in all hypertensives? Subgroup analyses of findings from the randomized FEVER trial. (2011) (128)
Randomized controlled trials of blood pressure lowering in hypertension: a critical reappraisal. (2015) (127)
1 – Cardiovascular Regulation during Sleep (1982) (127)
Effects of blood pressure-lowering on outcome incidence in hypertension: 5. Head-to-head comparisons of various classes of antihypertensive drugs – overview and meta-analyses (2015) (126)
Studies of the Absorption and Removal of Propranolol in Hypertensive Patients during Therapy (1975) (124)
Comparative effects of candesartan and enalapril on left ventricular hypertrophy in patients with essential hypertension: the candesartan assessment in the treatment of cardiac hypertrophy (CATCH) study (2002) (122)
Baseline Values but Not Treatment-Induced Changes in Carotid Intima-Media Thickness Predict Incident Cardiovascular Events in Treated Hypertensive Patients: Findings in the European Lacidipine Study on Atherosclerosis (ELSA) (2009) (122)
Prevalence and correlates of left atrial enlargement in essential hypertension: role of ventricular geometry and the metabolic syndrome: The Evaluation of Target Organ Damage in Hypertension study (2005) (122)
Systolic and pulse blood pressures (but not diastolic blood pressure and serum cholesterol) are associated with alterations in carotid intima–media thickness in the moderately hypercholesterolaemic hypertensive patients of the Plaque Hypertension Lipid Lowering Italian Study (2001) (121)
Tolerability of long-term treatment with lercanidipine versus amlodipine and lacidipine in elderly hypertensives. (2002) (121)
EEG arousal following inactivation of the lower brain stem by selective injection of barbiturate into the vertebral circulation (1959) (120)
Visit-to-Visit Blood Pressure Variability, Carotid Atherosclerosis, and Cardiovascular Events in the European Lacidipine Study on Atherosclerosis (2012) (117)
Calculation of trough: peak ratio of antihypertensive treatment from ambulatory blood pressure: methodological aspects (1995) (116)
Bottom blood pressure or bottom cardiovascular risk? How far can cardiovascular risk be reduced? (2009) (114)
Early 24-hour blood pressure elevation in normotensive subjects with parental hypertension. (1990) (113)
Usefulness of heart rate to predict cardiac events in treated patients with high-risk systemic hypertension. (2012) (111)
Cardiovascular changes during naturally elicited fighting behavior in the cat. (1969) (110)
Effects of blood pressure lowering on outcome incidence in hypertension: 3. Effects in patients at different levels of cardiovascular risk – overview and meta-analyses of randomized trials (2014) (109)
Systolic vs diastolic blood pressure control in the hypertensive patients of the PAMELA population. Pressioni Arteriose Monitorate E Loro Associazioni. (2002) (109)
Ambulatory blood pressure monitoring in the evaluation of antihypertensive treatment: additional information from a large data base. (1995) (108)
A study of pontine lesions suppressing deep sleep in the cat. (1965) (105)
Pulse pressure and isolated systolic hypertension: Association with microalbuminuria (2000) (105)
Influence of gender and age on preventing cardiovascular disease by antihypertensive treatment and acetylsalicylic acid. The HOT study (2000) (104)
Vasomotor regulation during sleep in the cat. (1971) (103)
Latin American guidelines on hypertension. Latin American Expert Group. (2009) (102)
Early alterations of the baroreceptor control of heart rate in patients with acute myocardial infarction. (1990) (101)
The Study on COgnition and Prognosis in the Elderly (SCOPE); outcomes in patients not receiving add-on therapy after randomization (2004) (101)
Protocol for prospective collaborative overviews of major randomized trials of blood-pressure-lowering treatments. World Health Organization-International Society of Hypertension Blood Pressure Lowering Treatment Trialists' Collaboration. (1998) (99)
Definition of kidney dysfunction as a cardiovascular risk factor: use of urinary albumin excretion and estimated glomerular filtration rate. (2008) (99)
Effects of calcium antagonists on the risks of coronary heart disease, cancer and bleeding (1997) (98)
Blood pressure variability in man: its relation to high blood pressure, age and baroreflex sensitivity. (1980) (97)
Neural regulation of renin release: experimental evidence and clinical implications in arterial hypertension. (1977) (97)
Summary of 1993 World Health Organisation-International Society of Hypertension guidelines for the management of mild hypertension. Subcommittee of WHO/ISH Mild Hypertension Liaison committee. (1993) (95)
Visit-to-visit blood pressure variability in the European Lacidipine Study on Atherosclerosis: methodological aspects and effects of antihypertensive treatment (2012) (94)
International Society of Hypertension (ISH): Statement on Blood Pressure Lowering and Stroke Prevention (2003) (93)
Relation of cardiovascular changes in fighting to emotion and exercise * (1971) (91)
Looking back, looking forward (2004) (91)
[ESH/ESC 2007 Guidelines for the management of arterial hypertension]. (2007) (91)
Latin American consensus on hypertension in patients with diabetes type 2 and metabolic syndrome. (2013) (90)
Low-dose aspirin does not interfere with the blood pressure-lowering effects of antihypertensive therapy. (2002) (90)
Retinal microvascular changes and target organ damage in untreated essential hypertensives (2004) (89)
Rationale and design for the Controlled ONset Verapamil INvestigation of Cardiovascular Endpoints (CONVINCE) Trial. (1998) (89)
Specific Appearance of Sympathetic Cholinergic Vasodilatation in Muscles during Conditioned Movements (1971) (89)
Control of blood pressure by carotid sinus baroreceptors in human beings. (1979) (88)
The Hypertension Optimal Treatment (HOT) Study--patient characteristics: randomization, risk profiles, and early blood pressure results. (1994) (88)
VALUE trial: Long-term blood pressure trends in 13,449 patients with hypertension and high cardiovascular risk (2003) (88)
Cardiovascular outcomes at different on-treatment blood pressures in the hypertensive patients of the VALUE trial. (2016) (87)
Prevalence and correlates of aortic root dilatation in patients with essential hypertension: relationship with cardiac and extracardiac target organ damage (2006) (87)
Modification of arterial baroreflexes by captopril in essential hypertension. (1982) (87)
Patterns of hypertension management in Italy: results of a pharmacoepidemiological survey on antihypertensive therapy (2000) (87)
Blood pressure and heart rate during natural sleep of the cat and their regulation by carotid sinus and aortic reflexes. (1965) (87)
Multiple risk factors in hypertension: results from the Gubbio Study (1990) (87)
Characteristics of 15314 Hypertensive Patients at High Coronary Risk. The VALUE Trial (2001) (86)
Hypertensive myocardial fibrosis. (2006) (86)
Blood pressure control in Italy: analysis of clinical data from 2005–2011 surveys on hypertension (2012) (86)
GENOME WIDE ASSOCIATION STUDY OF BLOOD PRESSURE EXTREMES IDENTIFIES VARIANT IN UMOD ASSOCIATED WITH HYPERTENSION: 6B.01 (2010) (85)
Benefit and harm of low-dose aspirin in well-treated hypertensives at different baseline cardiovascular risk (2002) (85)
The relation between electro-cortical waves and responsiveness of the cortico-spinal system. (1956) (84)
Haemodynamic responses and renin release during stimulation of afferent renal nerves in the cat. (1976) (82)
Reproducibility of nocturnal blood pressure fall in early phases of untreated essential hypertension: a prospective observational study (2004) (82)
Cardiovascular regulation during sleep. (1982) (80)
Indexation of left ventricular mass to body surface area and height to allometric power of 2.7: is the difference limited to obese hypertensives? (2009) (80)
Clinical pharmacodynamics of nebivolol: new evidence of nitric oxide‐mediated vasodilating activity and peculiar haemodynamic properties in hypertensive patients (2004) (79)
Risk assessment and treatment benefit in intensively treated hypertensive patients of the Hypertension Optimal Treatment (HOT) study (2001) (78)
The Study on COgnition and Prognosis in the Elderly (SCOPE) – Major CV events and stroke in subgroups of patients (2005) (78)
Control of renin release: a review of experimental evidence and clinical implications. (1976) (77)
Effect of rimonabant on blood pressure in overweight/obese patients with/without co-morbidities: analysis of pooled RIO study results (2008) (75)
Blood pressure targets of antihypertensive treatment: up and down the J-shaped curve. (2010) (74)
Effects of renal denervation on renin release in response to tilting and furosemide. (1977) (74)
Effects of blood-pressure-lowering treatment in hypertension: 9. Discontinuations for adverse events attributed to different classes of antihypertensive drugs meta-analyses of randomized trials (2016) (74)
Facts and fallacies of blood pressure control in recent trials: implications in the management of patients with hypertension (2009) (73)
Atrial natriuretic peptide and hemodynamic changes during normal human pregnancy. (1995) (73)
Prevalence and incidence of the metabolic syndrome in the European Lacidipine Study on Atherosclerosis (ELSA) and its relation with carotid intima–media thickness (2007) (73)
Association of systolic blood pressure levels with cardiovascular events and all-cause mortality among older adults taking antihypertensive medication. (2014) (73)
Effects of individual risk factors on the incidence of cardiovascular events in the treated hypertensive patients of the Hypertension Optimal Treatment Study (2001) (73)
Short-term reproducibility of a non-dipping pattern in type 2 diabetic hypertensive patients (2006) (73)
Left ventricular concentric remodelling and carotid structural changes in essential hypertension (1996) (72)
Assessment of long-term antihypertensive treatment by clinic and ambulatory blood pressure: data from the European Lacidipine Study on Atherosclerosis (2007) (71)
Transient but not sustained blood pressure increments by occupational noise. An ambulatory blood pressure measurement study (2001) (71)
Management of the hypertensive patient with elevated heart rate: Statement of the Second Consensus Conference endorsed by the European Society of Hypertension. (2016) (69)
Neural mechanisms underlying the enduring EEG and behavioral activation in the midpontine pretrigeminal cat (1959) (69)
Blood pressure and LDL-cholesterol targets for prevention of recurrent strokes and cognitive decline in the hypertensive patient: design of the European Society of Hypertension-Chinese Hypertension League Stroke in Hypertension Optimal Treatment randomized trial. (2014) (69)
Home blood pressure measurement and its relationship with blood pressure control in a large selected hypertensive population (2004) (68)
Evidence-based medicine in hypertension: what type of evidence? (2005) (68)
Effects of blood-pressure-lowering treatment on outcome incidence. 12. Effects in individuals with high-normal and normal blood pressure: overview and meta-analyses of randomized trials (2017) (68)
Prediction of cardiovascular outcome by estimated glomerular filtration rate and estimated creatinine clearance in the high-risk hypertension population of the VALUE trial (2007) (68)
Converting-enzyme inhibition and coronary blood flow. (1987) (67)
Inhibitory control of sinocarotid pressoceptive afferents on hypothalamic autonomic activity and sham rage behavior (1960) (66)
Effects of blood pressure lowering treatment in hypertension: 8. Outcome reductions vs. discontinuations because of adverse drug events – meta-analyses of randomized trials (2016) (66)
Reduced nocturnal fall in blood pressure, assessed by two ambulatory blood pressure monitorings and cardiac alterations in early phases of untreated essential hypertension (2003) (66)
Left ventricular diastolic dysfunction in elderly hypertensives: results of the APROS-diadys study (2007) (66)
Non-dipper treated hypertensive patients do not have increased cardiac structural alterations (2003) (65)
Natriuretic effect of calcium antagonists. (1985) (65)
Study on COgnition and Prognosis in the Elderly (SCOPE): Baseline Characteristics (2000) (64)
Age and target organ damage in essential hypertension: role of the metabolic syndrome. (2007) (64)
Cardiac and carotid structure in patients with established hypertension and white‐coat hypertension (1995) (62)
Neural control of renin release. (1975) (62)
Low Muscular Mass and Overestimation of Microalbuminuria by Urinary Albumin/Creatinine Ratio (2006) (61)
Ambulatory blood pressure normalcy: the PAMELA Study. (1991) (61)
Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis (2021) (60)
Blood pressure-lowering treatment strategies based on cardiovascular risk versus blood pressure: A meta-analysis of individual participant data (2018) (59)
Interactions between Sino‐aortic Reflexes and Cardiovascular Effects of Sleep and Emotional Behavior in the Cat (1976) (59)
Prevalence of Left Ventricular Hypertrophy and Carotid Thickening in a Large Selected Hypertensive Population: Impact of Different Echocardiographic and Ultrasonographic Diagnostic Criteria (2001) (59)
Statins, antihypertensive treatment, and blood pressure control in clinic and over 24 hours: evidence from PHYLLIS randomised double blind trial (2010) (59)
Cardiovascular Reflexes and Hypertension (1991) (59)
Health-related quality of life during treatment of elderly patients with hypertension: results from the Study on COgnition and Prognosis in the Elderly (SCOPE) (2004) (58)
Hemodynamic responses to different emotional stimuli in the cat: patterns and mechanisms. (1972) (58)
Longing for clinical excellence: a critical outlook into the NICE recommendations on hypertension management – is nice always good? (2012) (57)
Left ventricular hypertrophy and cardiovascular risk stratification: impact and cost-effectiveness of echocardiography in recently diagnosed essential hypertensives (2006) (57)
Effects of blood pressure-lowering treatment. 6. Prevention of heart failure and new-onset heart failure – meta-analyses of randomized trials (2016) (57)
No evidence for a J-shaped curve in treated hypertensive patients with increased cardiovascular risk: The VALUE trial (2016) (57)
The 1996 report of a World Health Organization expert committee on hypertension control. (1996) (56)
PRESSOCEPTIVE AND CHEMOCEPTIVE AORTIC REFLEXES IN DECORTICATE AND IN DECEREBRATE CATS. (1965) (56)
Impact of the Gubbio population study on community control of blood pressure and hypertension (2001) (56)
Neural and Non-neural Mechanisms influencing Circulation during Sleep (1969) (55)
Effects of angiotensin and angiotensin blockade on coronary circulation and coronary reserve. (1988) (55)
Evaluation of target organ damage in arterial hypertension: which role for qualitative funduscopic examination? (2001) (54)
Prevalence of home blood pressure measurement among selected hypertensive patients: Results of a multicenter survey from six hospital outpatient hypertension clinics in Italy (2005) (54)
Absolute and relative changes in carotid intima–media thickness and atherosclerotic plaques during long-term antihypertensive treatment: further results of the European Lacidipine Study on Atherosclerosis (ELSA) (2004) (54)
Findings and implications of the Study on COgnition and Prognosis in the Elderly (SCOPE) – A review (2006) (53)
Efficacy, Tolerability, and Impact on Quality of Life of Long-Term Treatment with Manidipine or Amlodipine in Patients with Essential Hypertension (2001) (53)
Lack of association between serum uric acid and organ damage in a never-treated essential hypertensive population at low prevalence of hyperuricemia. (2007) (53)
Prevalence and correlates of advanced retinopathy in a large selected hypertensive population. The Evaluation of Target Organ Damage in Hypertension (ETODH) study (2005) (53)
Defining ambulatory and home blood pressure normality: further considerations based on data from the PAMELA study. (2001) (53)
Hypotensive and Renal Effects of Diazoxide, a Sodium‐Retaining Benzothiadiazine Compound (1963) (53)
VALUE trial: Long-term blood pressure trends in 13,449 patients with hypertension and high cardiovascular risk. (2004) (52)
Riskard 2005. New tools for prediction of cardiovascular disease risk derived from Italian population studies. (2005) (51)
The first report of the Systolic and Pulse Pressure (SYPP) Working Group. (1999) (51)
Tonic Reflex Regulation of the Cat's Blood Pressure Through Vagal Afferents from the Cardiopulmonary Region (1962) (50)
Plasma catecholamines do not invariably reflect sympathetically induced changes in blood pressure in man. (1983) (50)
Regulation of renal circulation during behavioral changes in the cat. (1974) (50)
Ambulatory blood pressure, target organ damage and aortic root size in never-treated essential hypertensive patients (2007) (49)
The role of ambulatory blood pressure monitoring in clinical practice. (1997) (49)
Postischemic left ventricular dysfunction is abolished by alpha-adrenergic blocking agents. (1998) (48)
Job strain and ambulatory blood pressure levels in a population-based employed sample of men from northern Italy. (1996) (48)
Effect of electrocortical arousal upon development and configuration of specific evoked potentials. (1956) (47)
Metabolic syndrome and left ventricular hypertrophy in a general population. Results from the Gubbio Study (2007) (46)
The Hypertension Optimal Treatment (HOT) Study: 12-month data on blood pressure and tolerability. With special reference to age and gender. (1995) (46)
Compliance to hypertension guidelines in clinical practice: a multicentre pilot study in Italy (2002) (46)
Neural factors contributing to renin release during reduction in renal perfusion pressure and blood flow in cats. (1976) (46)
Guidelines on the management of arterial hypertension and related comorbidities in Latin America. (2017) (46)
Cognitive Function and Health-Related Quality of Life in Elderly Patients with Hypertension - Baseline Data from the Study on COgnition and Prognosis in the Elderly (SCOPE) (2002) (46)
Effects of Single and Repeated Doses of the Calcium Antagonist Felodipine on Blood Pressure, Renal Function, Electrolytes and Water Balance, and Renin‐Angiotensin-Aldosterone System in Hypertensive Patients (1986) (45)
Impact of nocturnal fall in blood pressure on early cardiovascular changes in essential hypertension. (1999) (45)
Effect of Long-Term Antihypertensive Treatment on White-Coat Hypertension (2014) (45)
The centenary of blood pressure measurement:a tribute to Scipione Riva‐Rocci (1996) (45)
The sympathetic nervous system in human hypertension. (2000) (44)
24-hour blood pressure control by once-daily administration of irbesartan assessed by ambulatory blood pressure monitoring. Irbesartan Multicenter Investigators' Group. (1997) (44)
Effects of exposure to high altitude on plasma endothelin-1 levels in normal subjects (1995) (44)
Blood pressure and low-density lipoprotein-cholesterol lowering for prevention of strokes and cognitive decline: a review of available trial evidence (2014) (44)
Antihypertensive efficacy of lercanidipine at 2.5, 5 and 10 mg in mild to moderate essential hypertensives assessed by clinic and ambulatory blood pressure measurements (1998) (44)
Isolated systolic hypertension in the young: a position paper endorsed by the European Society of Hypertension (2018) (44)
Reflex chemoceptive excitation of diencephalic sham rage behavior (1961) (44)
Midbrain course of descending pathways mediating sham rage behavior. (1963) (43)
Prognostic value of ambulatory blood pressure monitoring. (1994) (43)
Reproducibility of dipping/nondipping pattern in untreated essential hypertensive patients: impact of sex and age (2007) (43)
Antihypertensive efficacy and safety of olmesartan medoxomil and ramipril in elderly patients with mild to moderate essential hypertension: the ESPORT study (2010) (42)
Choice of antihypertensive drugs in the European Society of Hypertension-European Society of Cardiology guidelines: specific indications rather than ranking for general usage. (2008) (42)
Prevalence of target organ damage in treated hypertensive patients: different impact of clinic and ambulatory blood pressure control (2000) (42)
Pulse pressure and isolated systolic hypertension: association with microalbuminuria. The GUBBIO Study Collaborative Research Group. (2000) (42)
Goals of antihypertensive treatment: prevention of cardiovascular events and prevention of organ damage. (1992) (42)
The Hypertension Optimal Treatment (HOT) Study: 24-month data on blood pressure and tolerability. (1997) (41)
Is retinal arteriolar–venular ratio associated with cardiac and extracardiac organ damage in essential hypertension? (2009) (41)
1989 guidelines for the management of mild hypertension: memorandum from a WHO/ISH meeting. (1989) (41)
Effects of celiprolol on reflex control of the cardiovascular system in essential hypertension. (1986) (41)
Role of calcium antagonists in systemic hypertension. (1987) (41)
Benefits and cost-effectiveness of antihypertensive therapy. The actuarial versus the intervention trial approach. (1996) (40)
Antihypertensive and renal effects of orally administered verapamil (1980) (40)
Candesartan cilexetil and enalapril are of equivalent efficacy in patients with mild to moderate hypertension. (1997) (40)
EEG activation patterns in the midpontine pretrigeminal cat following sensory deafferentation (1959) (39)
Cardiovascular Changes during Preparation for Fighting Behaviour in the Cat (1968) (39)
Association of central and peripheral pulse pressure with intermediate cardiovascular phenotypes (2012) (39)
Effects of Prazosin on Autonomic Control of Circulation in Essential Hypertension (1980) (39)
Renal afferents signaling diuretic activity in the cat. (1993) (39)
Effects of blood pressure-lowering treatment on cardiovascular outcomes and mortality: 14 – effects of different classes of antihypertensive drugs in older and younger patients overview and meta-analysis (2018) (38)
Results of the Controlled ONset Verapamil INvestigation of Cardiovascular Endpoints (CONVINCE) trial by geographical region (2005) (38)
Characteristics of 15,314 hypertensive patients at high coronary risk. The VALUE trial. The Valsartan Antihypertensive Long-term Use Evaluation. (2001) (38)
Effects of cardiac denervation on blood pressure and heart rate during natural sleep in the cat. (1968) (38)
Isolated ambulatory hypertension and changes in target organ damage in treated hypertensive patients (2005) (38)
SPRINT Blood Pressure (2017) (37)
Improving cardiovascular risk stratification in essential hypertensive patients by indexing left ventricular mass to height2.7 (2009) (37)
Ambulatory blood pressure, target organ damage and left atrial size in never-treated essential hypertensive individuals (2005) (37)
Metabolic syndrome and biventricular hypertrophy in essential hypertension (2009) (37)
New year, new challenges. (2003) (36)
Serum uric acid and eGFR_CKDEPI differently predict long-term cardiovascular events and all causes of deaths in a residential cohort. (2014) (36)
Coping with the challenges of the next four years (2002) (36)
Awareness of hypertension guidelines in primary care: results of a regionwide survey in Italy (2003) (36)
Indexation criteria of ventricular mass and predictive role of blood pressure and body composition. (2005) (35)
Trough: peak ratio of the blood pressure response to dihydropyridine calcium antagonists (1994) (35)
Protein intake and kidney function in the middle-age population: contrast between cross-sectional and longitudinal data. (2014) (35)
Cardiovascular risk stratification in hypertensive patients: Impact of echocardiography and carotid ultrasonography (2001) (35)
Prevalence of episodes of ST‐segment depression among mild‐to‐moderate hypertensive patients in northern Italy: The Cardioscreening Study (1998) (35)
Differences between office and ambulatory blood pressures in children and adolescents attending a hospital hypertension clinic (2013) (35)
Reflex chemoceptive regulation of arterial pressure during natural sleep in the cat. (1968) (35)
Cardiovascular disease and the kidney: an epidemiologic overview. (1999) (35)
Overview of cardiovascular reflexes in hypertension. (1979) (34)
Effect of angiotensin converting enzyme inhibition on cardiovascular regulation during reflex sympathetic activation in sodium-replete patients with essential hypertension. (1989) (34)
Effect of stress on diagnosis of hypertension. (1991) (34)
Influence of gender and age on preventing cardiovascular disease by antihypertensive treatment and acetylsalicylic acid. The HOT study. Hypertension Optimal Treatment. (2000) (34)
Relationship between the hypotensive and renin-stimulating actions of diuretic therapy in hypertensive patients. (1978) (34)
Body mass index, nocturnal fall in blood pressure and organ damage in untreated essential hypertensive patients (2008) (34)
Arterial baroreceptor control of blood pressure in man. (1984) (34)
Effects of blood pressure-lowering treatment on cardiovascular outcomes and mortality: 13 – benefits and adverse events in older and younger patients with hypertension overview, meta-analyses and meta-regression analyses of randomized trials (2018) (33)
Ultrasonographic evaluation of cardiac and vascular changes in young borderline hypertensives. (1993) (33)
Cohort profile: The Gubbio Population Study. (2014) (33)
Cardiac structural and functional changes during long-term antihypertensive treatment with lacidipine and atenolol in the European Lacidipine Study on Atherosclerosis (ELSA) (2005) (33)
5.4 Studies on Left Ventricular Hypertrophy Regression in Arterial Hypertension: A Clear Message For The Clinician? (2008) (32)
Felodipine, A New Vasodilating Drug: Blood Pressure, Cardiac, Renal, and Humoral Effects in Hypertensive Patients (1984) (32)
Platt versus Pickering: an episode in recent medical history. By J. D. Swales, editor. An essay review. (1986) (32)
High prevalence of retinal vascular changes in never‐treated essential hypertensives: an inter‐ and intra‐observer reproducibility study with non‐mydriatic retinography (2004) (32)
Cardiovascular outcomes in hypertensive patients: comparing single-agent therapy with combination therapy (2012) (32)
Quality control of B-mode ultrasonic measurement of carotid artery intima–media thickness: the European Lacidipine Study on Atherosclerosis (2005) (32)
Hyperlipidemia in the hypertensive patient. (1994) (32)
Improvement of patients’ knowledge by a single educational meeting on hypertension (2001) (32)
Prevalence of type 2 diabetes among patients with hypertension under the care of 30 Italian clinics of hypertension: results of the (Iper)tensione and (dia)bete study (2008) (31)
Carotid Sinus and Aortic Reflexes in the Regulation of Circulation during Sleep (1965) (31)
Latin American consensus on diabetes mellitus and hypertension. (2004) (31)
Reflex Cardiovascular Regulation in Humans (1985) (31)
Prevalence and clinical correlates of right ventricular hypertrophy in essential hypertension (2009) (31)
MASked-unconTrolled hypERtension management based on office BP or on ambulatory blood pressure measurement (MASTER) Study: a randomised controlled trial protocol (2018) (31)
The antiatherogenic effects of antihypertensive drugs: experimental and clinical evidence. (1992) (31)
Mechanisms of blood pressure variability in man. (1985) (31)
The risk functions incorporated in Riscard 2002: a software for the prediction of cardiovascular risk in the general population based on Italian data. (2002) (31)
Role of sinoaortic reflexes in hemodynamic patterns of natural defense behaviors in the cat. (1981) (30)
Angiotensin II receptor blockers and cardiovascular protection: Focus on left ventricular hypertrophy regression and atrial fibrillation prevention (2008) (29)
Effects of pentoxifylline on inflammatory markers and blood pressure: a systematic review and meta-analysis of randomized controlled trials (2016) (29)
Antihypertensive therapy: how to evaluate the benefits. (1997) (29)
Continuation of the ESH-CHL-SHOT trial after publication of the SPRINT: rationale for further study on blood pressure targets of antihypertensive treatment after stroke. (2016) (29)
Alpha 1-blocking properties of carvedilol during acute and chronic administration. (1992) (28)
The VALUE Trial (2005) (28)
SPRINT Blood Pressure: Sprinting Back to Smirk's Basal Blood Pressure? (2017) (28)
The old Editors' new prologue (2000) (28)
Red blood cell count in short-term prediction of cardiovascular disease incidence in the Gubbio population Study (2002) (28)
DISTRIBUTION OF ELECTRICAL RESPONSES TO SOMATIC STIMULI IN THE DIENCEPHALON OF THE CAT, WITH SPECIAL REFERENCE TO THE HYPOTHALAMUS. (1965) (28)
Cardiovascular risk stratification according to the 2003 ESH‐ESC guidelines in uncomplicated patients with essential hypertension: comparison with the 1999 WHO/ISH guidelines criteria (2004) (28)
Brain stem mechanisms of sleep. (1967) (27)
On the importance of estimating renal function for cardiovascular risk assessment. (2004) (27)
Assessment of carotid plaque composition in hypertensive patients by ultrasonic tissue characterization: a validation study (2002) (27)
DOES THE BARORECEPTOR‐HEART RATE REFLEX INDICATE THE CAPACITY OF THE ARTERIAL BARORECEPTORS TO CONTROL BLOOD PRESSURE? (1980) (27)
Antihypertensive Treatment and Blood Pressure in Diabetic and Nondiabetic Patients (2011) (27)
Carotid wall composition in hypertensive patients after 4-year treatment with lacidipine or atenolol: an echoreflectivity study (2005) (27)
An electrophysiological analysis of pontine reticular regions showing different anatomical organization (1957) (26)
Antihypertensive efficacy of manidipine and enalapril in hypertensive diabetic patients. (2000) (26)
Sympathomoderating influence of benazepril in essential hypertension (1992) (26)
Clinical Perspective on Antihypertensive Drug Treatment in Adults With Grade 1 Hypertension and Low-to-Moderate Cardiovascular Risk: An International Expert Consultation. (2017) (26)
The hypertensive patient with multiple risk factors: is treatment really so difficult? (1997) (25)
Double‐Blind Comparison of the Cardioselective &bgr;‐Blockers Bisoprolol and Atenolol in Hypertension: The Bisoprolol International Multicenter Study (BIMS) (1985) (25)
MICROELECTRODE RECORDING OF SLOW WAVE AND UNIT RESPONSES TO AFFERENT STIMULI IN THE HYPOTHALAMUS OF THE CAT. (1965) (25)
Hypertension: Cardiac hypertrophy as a target of antihypertensive therapy (2010) (25)
Evaluation of organ damage in hypertension. (1993) (25)
Impairment of the arterial baroreflex during symptomatic and silent myocardial ischemia in humans. (1993) (25)
Is there a relationship between left ventricular mass and plasma glucose and lipids independent of body mass index? Results of the Gubbio Study. (2003) (25)
Clinical results of the Verapamil inHypertension and Atherosclerosis Study. VHAS Investigators. (1997) (25)
The use of drug concentration measurements in studies of the therapeutic response to propranolol. (1976) (25)
Antihypertensive treatment and risk of cancer: an individual participant data meta-analysis (2021) (25)
Carotid sinus reflexes during postural changes, naturally elicited fighting behaviour, and phases of sleep in the cat. (1985) (25)
An international trial of antihypertensive therapy in elderly patients. Objectives, protocol and organization. European Working Party on High Blood Pressure in the Elderly (EWPHE). (1985) (25)
First risk functions for prediction of coronary and cardiovascular disease incidence in the Gubbio Population Study. (2000) (25)
Twenty-four-hour ambulatory blood pressure evaluation of antihypertensive agents. (1997) (25)
How reliable is isolated clinical hypertension defined by a single 24-h ambulatory blood pressure monitoring? (2007) (24)
Plasma catecholamines and blood pressure responses to the carotid baroreceptor reflex in essential hypertension. (1979) (24)
Lack of correlation between left ventricular mass and diameter of left coronary artery main trunk in hypertensive patients. (1999) (24)
Factors influencing the carotid baroreceptor response to pressure changes in a neck chamber. (1976) (24)
Influence of high cardiovascular risk in asymptomatic people on the duration and cost of sick leave: results of the ICARIA study. (2014) (24)
Pathophysiology of hypertension : cardiovascular aspects (1986) (24)
Contribution of fixed low-dose combinations to initial therapy in hypertension (1999) (23)
Antiatherosclerotic effects of antihypertensive drugs: recent evidence and ongoing trials. (1996) (23)
Evaluating the benefits of an antihypertensive agent using trials based on event and organ damage: the Systolic Hypertension in the Elderly Long-term Lacidipine (SHELL) trial and the European Lacidipine Study on Atherosclerosis (ELSA) (1995) (23)
Brain stem-limbic connections, and the electrographic aspects of deep sleep in the cat. (1965) (22)
Measurement of electrical responsiveness of cortico-spinal efferents in cat and monkey. (1955) (22)
Guidelines for the management of hypertension: the World Health Organization/International Society of Hypertension view. World Health Organization. International Society of Hypertension. (1995) (22)
Methyldopa and neural control of circulation in essential hypertension. (1980) (22)
The sympathetic nervous system in human hypertension. (1997) (22)
Short-term Reproducibility of Nocturnal Non-dipping Pattern in Recently Diagnosed Essential Hypertensives (2002) (22)
Sympathoexcitatory responses to the acute blood pressure fall induced by central or peripheral antihypertensive drugs. (2000) (22)
Metabolic syndrome and target organ damage: role of blood pressure (2008) (22)
Comparison of candesartan versus enalapril in essential hypertension. Italian Candesartan Study Group. (2001) (22)
Hypertension Guidelines: Is It Time to Reappraise Blood Pressure Thresholds and Targets? Position Statement of the Latin American Society of Hypertension (2016) (22)
Left ventricular hypertrophy in treated hypertensive patients with good blood pressure control outside the clinic, but poor clinic blood pressure control (2003) (22)
Evaluation of the antihypertensive effect of celiprolol by ambulatory blood pressure monitoring. (1988) (21)
Interactions between the sympathetic nervous system and the kidney: experimental observations. (1985) (21)
Blood pressure control in a hypertension hospital clinic. (1999) (21)
Higher cardiovascular risk and impaired benefit of antihypertensive treatment in hypertensive patients requiring additional drugs on top of randomized therapy: is adding drugs always beneficial? (2012) (21)
ACE inhibitor ramipril is more effective than the beta-blocker atenolol in reducing left ventricular mass in hypertension. Results of the RACE (ramipril cardioprotective evaluation) study on behalf of the RACE study group. (1995) (21)
Relation of urinary albumin excretion to coronary heart disease and low renal function: role of blood pressure. (2004) (21)
Antihypertensive therapy in patients above age 60 with systolic hypertension. A progress report of the European Working Party on High Blood Pressure in the Elderly (EWPHE). (1982) (21)
How much should blood pressure be lowered? The problem of the J-shaped curve. (1989) (21)
Latin American Consensus on the management of hypertension in the patient with diabetes and the metabolic syndrome. (2019) (21)
Diffuse and specific activation of sympathetic cholinergic fibers of the cat. (1973) (21)
International Society of Hypertension (ISH): statements on blood pressure and stroke (2003) (20)
Vascular wall thickness in hypertension: the Perindopril Regression of Vascular Thickening European Community Trial (PROTECT) (1993) (20)
Does beta 1-selective agonistic activity interfere with the antihypertensive efficacy of beta 1-selective blocking agents? (1985) (20)
Neural, hemodynamic, and renal responses to stimulation of intestinal receptors. (1987) (20)
Investigation of reflexes from volume and baroreceptors during converting-enzyme inhibition in humans. (1989) (20)
Twenty-four hour and early morning blood pressure control of olmesartan vs. ramipril in elderly hypertensive patients: pooled individual data analysis of two randomized, double-blind, parallel-group studies (2012) (20)
Blood pressure control in a hypertension hospital clinic (1999) (20)
Echocardiographic and ultrasonographic evaluation of cardiac and vascular hypertrophy in patients with essential hypertension. (1992) (20)
Twenty-four-hour blood pressure profile and blood pressure variability in untreated hypertension and during antihypertensive treatment by once-a-day nadolol. (1984) (19)
Relationship between plasma insulin and left ventricular mass in normotensive participants of the Gubbio Study (2003) (19)
Woven left coronary artery disease. (1995) (19)
Nocturnal non‐dipping pattern in untreated hypertensives at different cardiovascular risk according to the 2003 ESH/ESC guidelines (2006) (19)
Cardiopulmonary receptor and arterial baroreceptor reflexes after acute myocardial infarction. (1992) (19)
Cardiovascular and renal effects of single administration of three different doses of isradipine in hypertensive patients. Dose-response curves of the different effects. (1989) (19)
An Italian chart for cardiovascular risk prediction. Its scientific basis. (2001) (19)
Hypertension: Meta-analyses: first-rank evidence or second-hand information? (2011) (19)
Is the nocturnal fall in blood pressure reduced in essential hypertensive patients with metabolic syndrome? (2004) (19)
Left ventricular concentric remodelling and extracardiac target organ damage in essential hypertension (2002) (19)
Prevalence of carotid atherosclerosis in hypertension: preliminary baseline data from the European Lacidipine Study on Atheroscelerosis (ELSA). (1996) (19)
Verapamil and propranolol: a comparison of two antihypertensive agents. (2009) (18)
Aspirin and Antiplatelet Drugs in the Prevention of Cardiovascular Complications of Diabetes (2007) (18)
Spatial patterns of ventricular repolarization in arterial hypertension (1960) (18)
Neural control of renin release. (1989) (18)
Ambulatory blood pressure monitoring in hypertension. (1993) (18)
Effects of blood pressure lowering on outcome incidence in hypertension: 4. Effects of various classes of antihypertensive drugs ^ Overview and (2015) (18)
Impact of Blood Pressure Control on Prevalence of Left Ventricular Hypertrophy in Treated Hypertensive Patients (2000) (18)
Electroencephalographic Desynchronization during Deep Sleep after Destruction of Midbrain-Limbic Pathways in the Cat (1963) (18)
Twenty-year cardiovascular and all-cause mortality trends and changes in cardiovascular risk factors in Gubbio, Italy: the role of blood pressure changes (2009) (18)
Left and right ventricular structural changes in obese hypertensives (2009) (18)
A double blind comparison of perindopril and atenolol in essential hypertension. (1990) (17)
Hypertension Optimal Treatment (HOT) trial (1998) (17)
IX - 1993 Guidelines for management of mild hypertension. Memorandum from a WHO/ISH meeting (1993) (17)
Effects of antihypertensive treatment on ultrasound measures of myocardial fibrosis in hypertensive patients with left ventricular hypertrophy: results of a randomized trial comparing the angiotensin receptor antagonist, candesartan and the angiotensin-converting enzyme inhibitor, enalapril (2009) (17)
Vagal and sinoaortic reflexes in postural control of circulation and renin release. (1979) (17)
Electrical carotid baroreceptor stimulation in resistant hypertension. (2010) (17)
Costs of implementing recommendations on hypertension management given in recent guidelines. (2003) (17)
Wars, war games, and dead bodies on the battlefield: variations on the theme of blood pressure variability. (2011) (17)
Hypertension: which aspects of hypertension should we impact on and how? (2006) (17)
Carotid artery wall alterations as intermediate end points. (1999) (17)
Resting and Postexercise Hemodynamic Effects of Carvedilol, a &bgr;‐Adrenergic Blocker and Precapillary Vasodilator in Hypertensive Patients (1987) (17)
The role of HDL cholesterol in metabolic syndrome predicting cardiovascular events. The Gubbio population study. (2011) (17)
Angiotensin converting enzyme inhibition in clinical practice. A re-examination of stepped-care: a retrospective and a prospective. (1985) (17)
Right ventricular wall thickness and function in hypertensive patients with and without left ventricular hypertrophy: echo-Doppler study. (1989) (17)
Control of circulation by arterial baroreceptors and cardiopulmonary receptors in hypertension. (1986) (17)
Afferent vagal control of renin release in the anesthetized cat (1978) (16)
Metabolic syndrome score and ambulatory blood pressure in untreated essential hypertension (2005) (16)
Emerging data on calcium‐channel blockers: The COHORT study (2003) (16)
Comparative measurements of immunoreactive renin, plasma renin activity and angiotensin II in human plasma. (1987) (16)
Population-based dose-response curve of glomerular filtration rate to dietary protein intake. (2015) (16)
A new dawn in cardiovascular protection III: The challenge of end-organ protection in high-risk patients - Introduction (2005) (16)
Summary of prazosin lipid studies (1984) (16)
Prevalence of physiological valvular regurgitation in hypertensive patients: echocardiographic and color Doppler study. (1992) (16)
Labetalol and 24‐Hour Monitoring of Arterial Blood Pressure in Hypertensive Patients (1981) (16)
24‐Hour blood pressure control by once‐daily administration of irbesartan assessed by ambulatory blood pressure monitoring (1997) (16)
The E.L.S.A. Trial: Protocol of a Randomized Trial to Explore the Differential Effect of Antihypertensive Drugs on Atherosclerosis in Hypertension (1994) (16)
A new sphygmomanometer. Sphygmomanometric technique. (1996) (15)
Essential hypertension and its causes: neural and non-neural mechanisms (2008) (15)
Effects of a Low-Sodium Diet on Antihypertensive and Natriuretic Responses to Acute Administration of Nifedipine (1987) (15)
Trough and peak effects of a single daily dose of nifedipine gastrointestinal therapeutic system (GITS) as assessed by ambulatory blood pressure monitoring. Italian Nifedipine GITS Study Group. (1994) (15)
Blood pressure response to labetalol in twice and three times daily administration during a 24-hour period. (1982) (15)
The antiatherogenic effects of antihypertensive treatment: Trials completed and ongoing (2001) (15)
Different relation between 24-h blood pressure and distensibility at different peripheral arteries. Data from the European Lacidipine Study on Atherosclerosis (ELSA) (2005) (15)
Twenty-four-hour hemodynamic profile during treatment of essential hypertension by once-a-day nadolol. (1983) (15)
Coronary response to diving in subjects with mild and severe left coronary artery disease. (1992) (15)
Treatment of hypertension in the elderly: effects on blood pressure, heart rate, and physical fitness. (1991) (15)
Trials investigating the anti-atherosclerotic effects of antihypertensive drugs (1996) (15)
Relationships of different types of event to cardiovascular death in trials of antihypertensive treatment: an aid to definition of total cardiovascular disease risk in hypertension (2014) (15)
Strategies for antihypertensive treatment decisions: how to assess benefits? (1997) (15)
Persistent Patterns of Wakefulness in the Pretrigeminal Midpontine Preparation (1958) (15)
Progressive effects of valsartan compared with amlodipine in prevention of diabetes according to categories of diabetogenic risk in hypertensive patients: The VALUE trial (2008) (15)
Typical and atypical coronary heart disease deaths and their different relationships with risk factors. The Gubbio residential cohort study. (2014) (15)
Vascular wall thickness in hypertension: the Perindopril Regression of Vascular Thickening European Community Trial (PROTECT). (1995) (14)
Short-term analysis of the relationship between blood pressure and urinary sodium excretion in normotensive subjects. (2000) (14)
Prevalence and correlates of multiple organ damage in a never-treated hypertensive population: role of ambulatory blood pressure (2008) (14)
Proteomic-Biostatistic Integrated Approach for Finding the Underlying Molecular Determinants of Hypertension in Human Plasma (2017) (14)
Evaluation of a Slow‐Release Clonidine Preparation by Direct Continuous Blood Pressure Recording in Essential Hypertensive Patients (1981) (14)
Prevention of hypertension and associated cardiovascular disease: a 1991 statement. Conclusions from a joint WHO/ISH meeting. (1992) (14)
Reflex control of circulation and angiotensin converting enzyme inhibition in man. (1988) (14)
Participation of the renin-angiotensin system in the maintenance of blood pressure during changes in posture in patients with essential hypertension. (1985) (14)
23 ELSA, European Lacidipine Study on Atherosclerosis (1993) (14)
Prospectives for angiotensin converting enzyme inhibition in heart diseases. (1985) (14)
Effects of blood-pressure-lowering treatment on outcome incidence in hypertension. 11. Effects of total cardiovascular risk and achieved blood pressure: overview and meta-analyses of randomized trials (2017) (14)
ASCENDING AFFERENT MECHANISMS MAINTAINING SHAM RAGE BEHAVIOR IN THE ACUTE THALAMIC CAT. (1963) (14)
Renal hemodynamic effects of dopexamine hydrochloride (1988) (13)
1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension endorsed by the Lebanese Hypertension League (1999) (13)
Effects of reversible renal denervation on haemodynamic and excretory functions of the ipsilateral and contralateral kidney in the cat. (1986) (13)
Intermediate endpoints for atherosclerosis in hypertension. (1997) (13)
Different effects of antihypertensive treatment on office and ambulatory blood pressure: a meta-analysis (2019) (13)
Impact of hypertension and antihypertensive treatment on organ damage. (1999) (13)
The ALLHAT trial: a verdict or a challenge? (2003) (13)
Lack of effect of short-term lisinopril administration on left ventricular filling dynamics in hypertensive patients with diastolic dysfunction. (1997) (13)
Antihypertensive effects of nifedipine gastrointestinal therapeutic system on clinic and ambulatory blood pressure in essential hypertensives (1993) (13)
Pathophysiology of hypertension : regulatory mechanisms (1986) (12)
Proceedings of a symposium: Calcium metabolism and calcium channel blockers for understanding and treating hypertension. (1984) (12)
Zofenopril plus hydrochlorothiazide: Combination therapy for the treatment of mild to moderate hypertension. (2006) (12)
Short-term analysis of the relationship between blood pressure and urinary sodium excretion in normotensive subjects (2000) (12)
Nitrendipine and ACE inhibitors. (1988) (12)
Dose-response curve and time course of the antihypertensive effect of SKF 92 657, a beta-receptor-blocking and vasodilating compound. (1980) (12)
Regulation of Circulation During Antihypertensive Treatment with Prazosin (1980) (12)
The Hyper‐Pract Study: A multicentre survey on the accuracy of the echocardiographic assessment of hypertensive left ventricular hypertrophy in clinical practice (2008) (12)
Evidence and wisdom: recommendations for forthcoming guidelines. (2011) (12)
[The effect of prolonged guanethidine administration on the kidney function of hypertensive patients]. (1960) (12)
HAEMODYNAMIC EFFECTS OF ISOMETRIC HANDGRIP EXERCISE IN PATIENTS CONVALESCENT FROM MYOCARDIAL INFARCTION (1978) (12)
One hundred years of auscultatory blood pressure: commemorating N. S. Korotkoff. (2005) (12)
Emotion and the cardiovascular system in the cat. (1972) (12)
CONTRIBUTION OF LOCAL ACTIVITY AND ELECTRIC SPREAD TO SOMATICALLY EVOKED POTENTIALS IN DIFFERENT AREAS OF THE HYPOTHALAMUS. (1965) (12)
Role of the renal nerves in the control of renin synthesis during different sodium intakes in the rat (2001) (12)
Effects of individual risk factors on the residual risk of cardiovascular events in a population of treated Chinese patients with hypertension: data from the Felodipine Event Reduction (FEVER) study (2010) (12)
Safety aspects of treatment with lacidipine--a slow-onset, long-acting calcium antagonist. (1996) (12)
Baroreceptor-heart rate reflex studied in normotensives and essential hypertensives by beat-to-beat analysis of twenty-four-hour blood pressure and heart rate (1987) (12)
Factors and consequences of hypertension. (2017) (12)
Cardiovascular effects of afferent renal nerve stimulation. (1987) (11)
Nicorandil, a new vasodilator drug, in patients with essential hypertension. (1989) (11)
Reversible alteration of myocardial function in gestational diabetes. (1983) (11)
Haemodynamic Alterations Triggered by Blood Pressure Assessments by the Doctor (1982) (11)
Antihypertensive treatment is not a risk factor for major cardiovascular events in the Gubbio residential cohort study (2015) (11)
Effects of afferent renal nerve stimulation on renal hemodynamic and excretory functions. (1984) (11)
Do we over treat mild hypertension? (2015) (11)
Structural cardiovascular adaptation and the consequences for baroreflexes. (1984) (11)
Reflex control of renin release in essential hypertension. (1978) (11)
Neural control of renin secretion (1984) (11)
Antihypertensive therapy: pride and prejudice. (1995) (11)
Neural control of the kidney--are there reno-renal reflexes? (1984) (11)
Use of intravenous digital subtraction ventriculography in the evaluation of left ventricle volumes and ejection fraction. (1991) (11)
Antihypertensive therapy: safety and efficacy of drugs and publications. (1996) (11)
VIEWPOINT The Antiatherosclerotic Effect of Calcium Antagonists in Man—What did MIDAS Actually Show? (1995) (11)
Control of regional circulations by the sino-aortic reflexes during desynchronised sleep in the cat. (1978) (11)
Monitoring of sympathetic activity in man: physiology and pharmacology. (1992) (11)
Effects of different sodium intakes on the antihypertensive and renal effects of single oral doses of nifedipine in hypertensive patients. (1987) (11)
Short and long-term impact of a structured educational program on the patient's knowledge of hypertension. (2000) (10)
Neural and psychological factors in coronary disease. (1974) (10)
Editors?? corner: debating the value of absolute versus relative risk (1996) (10)
Short- and long-term perspectives of antihypertensive therapy. An introduction. (1993) (10)
PROLONGED INTRA-ARTERIAL BLOOD-PRESSURE RECORDING IN DIAGNOSIS OF PHÆOCHROMOCYTOMA (1979) (10)
The issue of quality of life in antihypertensive therapy. (1993) (10)
EXCITATION AND INHIBITION OF SHAM RAGE BEHAVIOR BY LOWER BRAIN STEM STIMULATION. (1963) (10)
Extracardiac organ damage in essential hypertensives with left ventricular concentric remodelling (2010) (10)
Results of antihypertensive treatment trials in the elderly. (2002) (10)
Human renovascular effects of dopexamine hydrochloride: A novel agonist of peripheral dopamine and beta2-adreno-receptors (2004) (10)
What should be learnt about the management of obstructive sleep apnea in hypertension? (2012) (10)
Coronary vascular reactivity and calcium antagonist therapy in patients with angina. (1994) (10)
[Effect of afferent vagal stimulation on the electroencephalogram of the cat in cerebral isolation]. (1952) (10)
Somatic functions of the nervous system. (1962) (10)
Clinical advantages of lipophilic dihydropyridines. (1998) (10)
Has Antihypertensive Treatment Prevented Vascular Disease or Vascular Events? (1992) (10)
Goals of antihypertensive treatment and planning of therapeutic trials. (1994) (10)
Heritability of blood pressure through latent curve trajectories in families from the Gubbio population study (2014) (10)
Calcium Antagonists and Neural Control of Circulation in Essential Hypertension (1987) (10)
Time-course of the anti-hypertensive action of atenolol: Comparison of response to first dose and to maintained oral administration (1980) (10)
Awareness of hypertension guidelines in general practice: a pilot study in Lombardy. (2002) (9)
The basic importance of the physiological approach in clinical medicine: the experience in the area of hypertension. (2005) (9)
Hypertension in the twentieth century: concepts and achievements (2004) (9)
Best antihypertensive strategies to improve blood pressure control in Latin America: position of the Latin American Society of Hypertension (2018) (9)
Which Drug for Which Patient? (1985) (9)
Carotid sinus reflex control of renin release in hypertensive subjects with high renin secretion. (1981) (9)
Antihypertensive Effect of a New Formulation of Slow Release Oxprenolol in Essential Hypertension (1987) (9)
The renin-angiotensin system and the heart. (1988) (9)
Ascending reticular influences upon thalamically evoked pyramidal discharges. (1956) (9)
Evidence-based medicine: an educational instrument or a standard for implementation? (1999) (9)
Treatment goals in hypertension. (1984) (9)
Renal reflexes in the regulation of blood pressure and sodium excretion. (1987) (9)
Control of renal renin release. (1987) (9)
Haemodynamic effects of ACE inhibitors. (1990) (9)
Marked blood pressure fluctuations during narcoleptic attacks alternating with abnormal wakefulness: effects of treatment with clonidine. (1989) (9)
Angiotensin‐Converting Enzyme Inhibitors in Essential Hypertension (1987) (9)
Volhard lecture: sympatho-renal interactions and blood pressure control. (1986) (9)
Effects of blood pressure reduction with trandolapril and enalapril on left ventricular hypertrophy and exercise tolerance (1993) (9)
The antiatherosclerotic effect of calcium antagonists in man--what did MIDAS actually show? Multicenter Isradipine Diuretic Atherosclerosis Study. (1995) (9)
Effects of angiotensin II receptor blockade‐based therapy with losartan on left ventricular hypertrophy and geometry in previously treated hypertensive patients (2006) (9)
Looking back on three years of editorship (1998) (9)
Humoral effects of selective adenosine agonists in spontaneously hypertensive rats (1996) (9)
Effects of fosinopril and pravastatin on progression of asymptomatic carotid atherosclerosis in hypertension: Results of the Plaque Hypertension Lipid Lowering Italian Study (PHYLLIS) (2003) (9)
Renal effects of calcium antagonists in hypertensive patients. (1985) (8)
Efficacy and tolerability of moexipril and nitrendipine in postmenopausal women with hypertension (1999) (8)
A welcome debate on how to measure the left ventricular mass. (1997) (8)
From risk factors to treatment of hypertension. (2016) (8)
Target blood pressure in elderly hypertensive patients and in patients with diabetes mellitus. (2014) (8)
Calcium Channel Blockers in Hypertension (2007) (8)
Acute and chronic converting enzyme inhibition reduces the vasomotor response to reflex sympathetic activation in man. (1985) (8)
Discussion on the natriuretic effect of calcium antagonists. (1987) (8)
190 Ambulatory and home blood pressure reference values: the Pamela Study (1993) (8)
How Should Elderly Hypertensive Patients Be Treated? (1989) (8)
Thou, gentle viper: an introduction. (1982) (8)
Interactions between the sympathetic nervous system and atrial natriuretic factor in the control of renal functions. (1990) (8)
Zofenopril plus Hydrochlorothiazide (2012) (8)
Change in cardiovascular risk profile by echocardiography in medium-risk elderly hypertensives (2003) (8)
Blood pressure decrease and responsiveness to renin-releasing stimuli under increasing doses of propranolol in patients with essential hypertension. (1975) (8)
Baroreceptor reflexes from different vascular areas in animals and man. (1976) (8)
Management of hypertension in patients with left ventricular hypertrophy (2007) (8)
Ambulatory heart rate and target organ damage in never-treated essential hypertensives (2008) (8)
Alterations in sympathetic nerve traffic during cigarette-smoking in man: a preliminary report. (1991) (8)
Antihypertensive and renal effects of tertatolol, a new beta-blocking agent, in hypertensive patients. (1986) (8)
The physiologic relevance of smooth twenty-four-hour blood pressure control. (1994) (8)
Natriuretic effects of calcium antagonists. Clinical implications. (1990) (8)
Alpha 1-Adrenoceptor blockade: dissociation of its effects on renin release and arterial blood pressure in man. (1981) (7)
Effects of a reversible ‘nephrectomy’ on renal sympathetic activity and blood pressure in the rat: evidence for an acute angiotensin‐mediated hypertension (2000) (7)
Doctor-elicited blood pressure rises at the time of sphygmomanometric blood pressure assessment persist over repeated visits. (1985) (7)
Local Tissue Lesions as a Means of Assessing the Local or Remote Origin of Evoked Potentials within the Brain (1965) (7)
Coronary blood flow in renovascular hypertension. (1993) (7)
Hemodynamic and neural effects of urapidil and prazosin in essential hypertensives. (1994) (7)
Left ventricular diastolic function in athletes and borderline hypertensives with mild cardiac hypertrophy. (1991) (7)
The new WHO Expert Committee Report on Hypertension Control. (1996) (7)
Neuronal nitric oxide synthase and renin stimulation by sodium deprivation are dependent on the renal nerves (2002) (7)
Addition of urapidil or metoprolol to the treatment of hypertensive non-responders to nifedipine monotherapy: efficacy and metabolic effects. Italian Urapidil Study Group. (1995) (7)
Perindopril: first-line treatment for hypertension. (1989) (7)
Searching for information from unreported trials--amnesty for the past and prospective meta-analyses for the future. (1998) (7)
Prevalence and correlates of multiple organ damage in referred treated hypertensives: data from the ETODH study (2008) (7)
Erratum: Hypertension: Which aspects of hypertension should we impact on and how? (Journal of Hypertension (2006) 24, SUPPL. 5 (S2-S5)) (2007) (7)
Arterial hypertension increases left ventricular mass: role of tight blood pressure control (2004) (7)
[Comparative study of the sali-diuretic action of hydro-chlorothiazide and chlorothiazide]. (1959) (7)
Effectiveness of Sepharose-bound trypsin versus liquid-phase trypsin plus benzamidine for activation of inactive renin in human plasma. (1987) (7)
Antihypertensive efficacy and influence on physical activity of three different treatments in elderly hypertensive patients. (1989) (7)
The dilemma of placebo controlled studies: scientific evidence, guidelines, ethics and regulatory recommendations. (2009) (7)
Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis (2022) (7)
Osmotic indices and kidney concentrating activity: population-based data on correlates and prognostic power (2018) (7)
Angiotensin converting enzyme inhibition and renin release from the kidney. (1989) (7)
Behavioral effects of electrical stimulation of group I muscle afferents in acute thalamic cats. (1968) (6)
Carotid atherosclerosis and cardiovascular risk stratification: Role and cost‐effectiveness of echo‐Doppler examination in untreated essential hypertensives (2006) (6)
Hypertension-related mortality and morbidity. (2015) (6)
Value of echocardiographic and ambulatory blood pressure monitoring in hypertension. (1989) (6)
Vascular and parenchymal lesions along with enhanced neurogenesis characterize the brain of asymptomatic stroke-prone spontaneous hypertensive rats (2013) (6)
Renal Effects of Felodipine in Hypertension (2012) (6)
AMBULATORY BLOOD PRESSURE MONITORING. DISUCSSION (1996) (6)
Role of the renal nerves and angiotensin II in the renal function curve. (1999) (6)
Ambulatory blood pressure monitoring. (1999) (6)
Abstract T MP99: What Are the Blood Pressure Levels Associated With the Lowest Stroke Rates in the Elderly? Findings From the Reasons for Geographic and Racial Differences in Stroke (regards) Cohort Study (2014) (6)
Comparison of the antihypertensive effect of urapidil and metoprolol in hypertension (2004) (6)
Factors influencing blood pressure levels. (2015) (6)
1991 Guidelines for the prevention of hypertension and associated cardiovascular disease (1992) (6)
Effects of amlodipine on coronary hemodynamics and vascular responses to sympathetic stimulation in patients with coronary heart disease. (1994) (6)
Central and reflex control of renin release. (1977) (6)
Atherosclerosis and calcium antagonists: the VHAS. The Verapamil-Hypertension Atherosclerosis Study (VHAS) Investigators. (1992) (6)
Stepwise Treatment of Hypertension (1990) (6)
Influence of different echocardiographic criteria for detection of left ventricular hypertrophy on cardiovascular risk stratification in recently diagnosed essential hypertensives (2001) (6)
Obstructive hypertrophic cardiomyopathy in type III glycogen-storage disease. (1997) (6)
Evaluation of a new non-invasive semiautomatic blood pressure monitoring device. (1987) (6)
Physiological Versus Pathological Hypertrophy (1997) (6)
Nifedipine Does Not Blunt the Aldosterone and Cardiovascular Response to Angiotensin II and Potassium Infusion in Hypertensive Patients (1988) (6)
Hemodynamic effects of once a day administration of combined chlorthalidone and metoprolol slow-release in essential hypertension. (1984) (6)
Calcium Antagonists and Responsiveness of the Adrenal Glands to Aldosterone-Releasing Stimuli in Hypertensive Patients (1987) (6)
Challenges in hypertension: prevalence, definition, mechanisms and management. (2014) (6)
AGE-DEPENDENT DIFFERENCES IN OFFICE (OBP) VS AMBULATORY BLOOD PRESSURE MONITORING (ABPM) IN HYPERTENSIVE CHILDREN AND ADOLESCENTS: 8C.03 (2010) (6)
Hypertension in Postmenopausal Women (1994) (5)
Neural influences on kidney function in the pathogenesis of arterial hypertension. (1985) (5)
Carotid baroreceptor reflex in normotensive and hypertensive subjects. (1976) (5)
Left ventricular hypertrophy regression with antihypertensive treatment: focus on candesartan (2003) (5)
Acute effects of cilazapril on coronary hemodynamics in patients with renovascular hypertension. (1992) (5)
[Prevention of coronary disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology (ESC), European Atherosclerosis Society (EAS) and European Society of Hypertension (ESH)]. (1995) (5)
Cardiac and carotid structure in arterial hypertension and in hypertrophic cardiomyopathy. (1995) (5)
Relation between the hypotensive and renin-suppressing activities of alpha methyldopa in hypertensive patients. (1977) (5)
Antihypertensive therapy: safety and efficacy of drugs and publications. (1996) (5)
Physiological versus pathological hypertrophy. The athlete and the hypertensive. (1997) (5)
Renin release and renal vasomotor changes during stimulation of the brain stem in the cat. (1973) (5)
Pathophysiology of Hypertension (1997) (5)
Mechanisms of arterial hypertension: role of neural control of renal functions. (1985) (5)
The 24 h blood pressure-R–R interval relation in ambulatory monitoring (2008) (5)
Functional evidence of inhibitory reno-renal reflexes in spontaneously hypertensive rats. (1996) (5)
Acute, chronic and postwithdrawal antihypertensive and renal effects of amlodipine in hypertensive patients. (1991) (5)
Effects of erythropoietin administration on blood pressure and urinary albumin excretion in rats. (1997) (5)
Looking forward with a grateful heart. (2010) (5)
The spinal course of the corticofugal fibers arising in the motor cortex of the cat. (1955) (5)
Prevention of coronary heart disease: the recommendations of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension. (1995) (5)
Antihypertensive Treatment: Is Blood Pressure‐Lowering the Only Goal? (1991) (5)
Neural Control of Circulation Before and After Intravenous Urapidil in Essential Hypertension (2012) (4)
Impact of carotid intima-media thickening on risk stratification in elderly hypertensives. (2003) (4)
Evaluation of the Antihypertensive Effect of TTS Clonidine by Multiple 24‐Hour Automatic Blood Pressure Monitoring (1986) (4)
The calcium channel blocker controversy in perspective. (1997) (4)
What format for hypertension guidelines: a challenge for authors and users. (2014) (4)
Is hypertension a fatal disease today? Proceedings of a satellite symposium held during the 21st European Meeting on Hypertension and Cardiovascular Prevention Milan (Italy), June 17-20, 2011. Foreword. (2011) (4)
International views of the use of calcium antagonists in the treatment of hypertension. (1985) (4)
Urapidil in hypercholesterolemic hypertensive patients. (1994) (4)
Can stent implantation and a-adrenergic blockade improve function of hibernated and stunned myocardium in AMI patients after thrombolysis? (1997) (4)
Renal and antihypertensive effects of felodipine in hypertensive patients. (1985) (4)
TACHYCARDIA IS A STRONG PREDICTOR OF CARDIOVASCULAR EVENTS IN THE VALUE TRIAL: 6A.04 (2010) (4)
Cortico-spinal responsiveness during EEG arousal in the cat. (1958) (4)
Moderate Leisure Time Physical Activity and Occurrence of Cardiovascular Events: A 10-year Follow-up in the Gubbio Population Study (2014) (4)
Round Table: What blood pressure to measure? (1991) (4)
Aortic coarctation suspected by Doppler echocardiography of renal arteries in hypertensive patients referred to a hospital outpatient hypertension clinic. (2005) (4)
Safety profile of lacidipine: update from a clinical trials database. (1999) (4)
Autonomic and renal effects of intravenous diazoxide. A study of the mechanisms of its hypotensive action in man (1970) (4)
Evaluation of subclinical cardiac damage in arterial hypertension: From guidelines to clinical practice (2010) (4)
Genetic and environmental factors in development of hypertension. (2016) (4)
Principal results of hypertension optimal treatment (HOT) study and their clinical impact. HOT cooperative group. (1999) (4)
Noradrenaline reactivity in patients with phaeochromocytoma before and after surgical correction. (1981) (4)
Blood Pressure Monitoring (2008) (4)
THE VALSARTAN ANTIHYPERTENSIVE LONGTERM USE EVALUATION (VALUE) TRIAL: FINAL PATIENTS DEMOGRAPHICS (2000) (4)
24h ambulatory blood pressure variability and carotid artery damage: baseline data from the European Lacidipine Study on Atherosclerosis (ELSA) (2000) (4)
Cardiovascular consequences of hypertension: therapeutic effects on organ damage and on cardiovascular events. (1994) (4)
Estimation of metabolic syndrome heritability in three large populations including full pedigree and genomic information (2019) (4)
Antihypertensive therapy and cardiovascular complications. (1986) (4)
Cardiovascular and renal effects of acute administration of a new hypotensive compound, guancydine (1971) (4)
The clinical role of angiotensin converting enzyme inhibitors in antihypertensive therapy in the 1990s. (1989) (4)
A Comparison of Blood Pressure Control in a Hypertension Hospital Clinic Between 1997 and 2000 (2002) (4)
Hypertension: Lower or higher blood-pressure targets for high-risk patients? (2016) (4)
The 24-Hour Efficacy of a New Once-Daily Formulation of Nifedipine (2012) (4)
White Coat Hypertension: The History of the Irresistible, Resistible Ascent of a Misnomer (2015) (4)
Hypertension: prognostic, diagnostic and therapeutic aspects. (2018) (4)
Differences in reflex control of arterial pressure and renin release during head-up tilting in the cat. (1978) (4)
Renin and the sympathetic nervous system. (1974) (4)
Patients with prehypertension - do we have enough evidence to treat them? (2014) (4)
Current standard of care in patients affected by coronary heart disease in Italy: the MC'95 study. (2002) (4)
[Practice guidelines 2007 for the treatment of arterial hypertension]. (2007) (4)
[Behavior and electroencephalographic picture in the cat after lesions, complete or partial, of the mesencephalic reticular substance]. (1956) (4)
Concepts of multiple risk factors management: the Gubbio Study (1990) (4)
Peripheral vascular effects of clonidine independent of a reduction in sympathetic activity [proceedings]. (1976) (4)
Risk of major gastrointestinal bleeding with aspirin (1999) (3)
First-line treatment in hypertension. Role of perindopril. (1990) (3)
Metabolic Syndrome in the PAMELA Population: Prevalence, Prognostic Value, Out-Of-Office Blood Pressures and Cardiac Damage (2005) (3)
Trends in hypertension control and left ventricular hypertrophy over three years. (2002) (3)
TIMI flow recovery after coronary stenting and a-adrenergic blocking treatment (1997) (3)
Influence of sleep on circulation in normal and hypertensive animals (1966) (3)
Post-Hoc Subgroup Analysis of a Randomized Controlled Trial Aspirin Is Beneficial in Hypertensive Patients With Chronic Kidney Disease: A (2010) (3)
24 H Ambulatory Blood Pressure Variability and Carotid Artery Damage: Baseline Data from the Elsa Study. (2000) (3)
THE ROLE OF EFFERENT AND AFFERENT RENAL NERVES IN THE RELEASE OF RENIN IN THE CAT (1977) (3)
Rational Approaches to Clinical Therapy (1980) (3)
THE EFFECT OF QUERCETIN ON BLOOD PRESSURE: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS (2016) (3)
Comparison of the echocardiographic effects induced by physiological ageing and hypertension on the left and right ventricle (1993) (3)
The role of the kidney in neurohormonal cardiovascular regulation. (1988) (3)
Renal afferents responsive to chemical and mechanical pelvic stimuli in the rabbit. (1997) (3)
Development of blood pressure lowering therapy from trials to practice (2004) (3)
Natriuretic Effects of Calcium Antagonists (2012) (3)
Effects of long-term blood pressure control on left and right ventricular structure and function in hypertensive patients. (1991) (3)
Acute modulation of arterial compliance in mild essential hypertension. (1991) (3)
Electrophysiological evidence of ipsilateral reno-renal reflexes in the cat. (1997) (3)
Agreement within Europe about antihypertensive treatment and education - results from the European Society of Hypertension questionnaire. (2010) (3)
Ambulatory blood pressure monitoring (1996) (3)
Tonic reflex regulation of the cat's blood pressure through vagal ‘non-aortic’ afferents (1962) (3)
What have we learned from the HOT (Hypertension Optimal Treatment) study? (1997) (3)
HYPERTENSION OPTIMAL TREATMENT (HOT) TRIAL. AUTHORS' REPLY (1998) (3)
New challenges in the disease management of hypertension. (2001) (3)
Guidelines for the management of hypertension: the world Health organisation/International society of Hypertension View (1995) (3)
White coat hypertension: An unresolved diagnostic and therapeutic problem (2014) (3)
Effects of antihypertensive treatment on vasopressin secretion and on its osmoregulation in moderate hypertension (1997) (3)
Opposite responses of muscle circulation to different emotional stimuli (1971) (3)
Estimating the glomerular filtration rate in the Spanish working population: chronic kidney disease prevalence and its association with risk factors (2014) (3)
Alterations of cardiovascular reflexes in hypertension. (1980) (3)
Prevalence of Home Blood Pressure Measurement Among Selected Hypertensive Patients: Results of a Multicenter Survey from Six Hospital Out-Patient Hypertension Clinics in Italy (2005) (3)
Do renal afferent fibres modulate the function of the contralateral kidney? (1983) (3)
Acute hypotensive and renin-stimulating actions of captopril before and during treatment with a beta-blocking drug. (1982) (3)
88 The Hypertension Optimal Treatment (HOT) study purpose and design (1993) (3)
Diabetes: Measuring interarm blood pressure differences in diabetes (2014) (3)
The effects of Mianserin therapy on plasma renin activity in depressed patients (1986) (3)
Vascular complications in hypertension: The VHAS study (1995) (3)
Regulation of renin secretion. (1977) (3)
CRYOACTIVATION FAILS TO AUGMENT PLASMA RENIN ACTIVITY IN THE CAT (1982) (3)
Editing a scientific journal: problems and challenges. (2008) (3)
[PP.12.09] MASKED-UNCONTROLLED HYPERTENSION MANAGEMENT BASED ON OFFICE BP OR ON OUT-OF-OFFICE (AMBULATORY) BP MEASUREMENT (MASTER): STUDY PROTOCOL (2017) (3)
Effects of dilevalol on forearm circulation in essential hypertension. (1989) (3)
Effects of presso- and chemoceptive components of the cat's aortic nerve on sham rage behaviour (1963) (3)
Clinical trials on the treatment of hypertension. A critical appraisal. (1986) (3)
Chapter 22 – Calcium Channel Blockers in Hypertension (2013) (3)
Cardiac structure and function before and after acute and chronic verapamil administration in hypertensive patients. (1991) (3)
Effect of Long-Term Antihypertensive Treatment on WhiteCoat Hypertension (3)
Targeting Hypertension with Valsartan: Lessons Learned from the Valsartan/HCTZ Versus Amlodipine in Stage II Hypertensive Patients (VAST) Trial (2006) (3)
Dissociation of the effects of α1-adrenergic blockade on blood pressure and renin release in patients with essential hypertension (1982) (3)
Introduction: the role of combination therapy in modern antihypertensive therapy. (2000) (2)
Therapeutic approaches, age and ethnicity in hypertension. (2017) (2)
What blood pressure levels should be treated? (2004) (2)
From lifestyle changes to outcomes in hypertension. (2017) (2)
Position of beta blockers in antihypertensive therapy. (1986) (2)
[OP.1A.08] COMPARISON BETWEEN OFFICE AND AMBULATORY BLOOD PRESSURE IN ASSESSING THE REDUCTION OF BLOOD PRESSURE: A META-ANALYSIS (2016) (2)
H53: Comparison of the antihypertensive efficacy of candesartan cilexetil versus placebo or enalapril in patients with mild to moderate essential hypertension (1997) (2)
Latin american consensus of hypertension in patients with type 2 diabetes and metabolic syndrome (2013) (2)
Cardiac and renal damage in the elderly hypertensive (2002) (2)
Reflex activity of single preganglionic sympathetic fibres during coronary occlusion (1969) (2)
Optimized Conditions for Trypsin Activation of Inactive Renin in Human Plasma (1984) (2)
Predictors of blood pressure control in the convince trial (2004) (2)
Contributions to debated problems. (2013) (2)
Challenges of hypertension and hypertension treatment. (2014) (2)
Introduction: Reducing cardiovascular risk: ONTARGET--a new standard in cardiovascular protection. (2009) (2)
Role of the renal nerves in renin release during suprarenal aortic stenosis in cats. (1976) (2)
Vascular complications in hypertension: the VHAS study. Verapamil-Hypertension Atherosclerosis Study. (1995) (2)
DIFFERENT EFFECTS OF ANTIHYPERTENSIVE THERAPIES BASED ON LOSARTAN OR ATENOLOL ON ULTRASOUND AND BIOCHEMICAL MARKERS OF MYOCARDIAL FIBROSIS: P2.70 (2004) (2)
Improving cardiovascular risk stratification in essential hypertensives by indexing left ventricular mass to height2.7 (2009) (2)
I028: Dissociation between the increments of plasma and urinary cyclic GMP during saline infusion in essential hypertensive patients (1998) (2)
Results of Experimental Studies Favoring the Hypothesis of the Influence of Stress on the Genesis of Hypertension (1984) (2)
1.2 Ambulatory Blood Pressure, Target Organ Damage and Aortic Root Size in Never Treated Essential Hypertensives (2007) (2)
Regional blood flows during desynchronized sleep in the cat (1969) (2)
Chapter 97 – The 2003 Guidelines for the Management of Hypertension of the European Society of Hypertension and European Society of Cardiology (2007) (2)
Left ventricular mass again: measurements and prognosis. (1998) (2)
Neurale Mechanismen emotionalen Verhaltens (1966) (2)
[Regulation of pulmonary circulation]. (1958) (2)
190 : the Pamela Study Ambulatory and home blood pressure reference values: the Pamela Study (1993) (2)
Factors influencing acute ischaemia-induced renal hypertension in rats (2002) (2)
The Development of New Antihypertensive Drugs with Specific Properties for the Treatment of Established Hypertension (1986) (2)
β-Blockers and Renin (1983) (2)
Alterations of systolic time intervals in the assessment of myocardial function during hypertensive pregnancy. (1983) (2)
Issues in the development of new combinations of blood pressure lowering drugs (2010) (2)
Salt, inflammation, pathophysiological mechanisms, and organ damage in hypertension. (2014) (2)
Hemodynamic effects of acute and prolonged administration of nitrendipine in essential hypertension. (1987) (2)
Efficacy and tolerability of moexipril and nitrendipine in postmenopausal women with hypertension. MADAM study group. Moexipril as Antihypertensive Drug After Menopause. (1999) (2)
DOES INCIDENCE OF CARDIOVASCULAR OUTCOMES REALLY INCREASE WHEN LOW SYSTOLIC AND DIASTOLIC BLOOD PRESSURES ARE ACHIEVED BY DRUG TREATMENT? FACTS IN THE FEVER TRIAL: 9A.02 (2010) (2)
On the state of the Journal (2006) (2)
Reciprocal changes in atrial natriuretic factor and aldosterone during angiotensin converting enzyme inhibition in man. (1989) (2)
Role of renal nerves in mediating the renal response to tilting (1983) (2)
Reversible Renal Nerve Denervation in the Cat: Effects on Haemodynamic and Excretory Functions of the Ipsilateral and Contralateral Kidneys (1982) (2)
Effects of adenosine receptor agonists on efferent renal nerve activity in anesthetized rats. (2000) (2)
Target Blood Pressure in Elderly Hypertensive Patients: How Low Should You Go? (2000) (2)
Risk of coronary disease and coronary complications by neural and psychological factors. (1975) (2)
Regulation of vasopressin release in moderately severe essential hypertension (1991) (2)
Reflex and brain stem inhibition of sham rage behaviour. (1968) (2)
VASOPRESSIN, HYPERTENSION AND ADRENAL STEROIDS: P1.102 (2004) (2)
55. Diuretic manoeuvres modify afferent renal nerve activity in cats (1991) (2)
Circulating and tissue renin-angiotensin system: present and future. (1989) (2)
Short-Term Reproducibility of Non-Dipping Pattern in Type 2 Diabetic Hypertensive Patients: 1.8 (2005) (2)
Introduction: Position of beta blockers in antihypertensive therapy (1986) (2)
Effects of Calcium Antagonists on Renal Hemodynamics and Water and Sodium Excretion in Hypertensive Patients (1987) (2)
Blood levels and pharmacokinetic studies of propranolol in chronic therapy (1974) (2)
Reading and citing from the Journal of Hypertension. (2007) (2)
Role of the renal nerves in the natriuretic response to vasopressin infusion. (1989) (2)
CARDIOVASCULAR RISK STRATIFICATION ACCORDING TO THE 2003 ESH-ESC GUIDELINES IN UNCOMPLICATED PATIENTS WITH ESSENTIAL HYPERTENSION: IMPACT OF TARGET ORGAN DAMAGE AND CONCOMITANT RISK FACTORS COMPARISON WITH THE 1999 WHO/ISH GUIDELINES (2004) (2)
Prevention of hypertension and associated cardiovascular disease. A 1995 statement. Conclusions from a joint WHO/ISH Meeting. (1996) (2)
COST-EFFECTIVENESS OF ANTIHYPERTENSIVE THERAPY : WHAT MESSAGE TO PATIENTS,DOCTORS AND HEALTH SERVICES? (1998) (2)
Analysis of the dynamics of renal vascular resistance and urine flow rate in the cat following electrical stimulation of the renal nerves. (1996) (2)
Mechanisms of renin release in response to tilting and furosemide (1974) (2)
Definition and classification of hypertension: the WHO criteria (2001) (1)
[Correlation between chemical and vagal regulation of respiration]. (1953) (1)
Guidelines and research upon which guidelines are founded. (2013) (1)
Serotonin and cardiovascular regulation: a new approach to hypertension. (1986) (1)
[Destruction of the periaqueductal gray matter and pseudorabies behavior of the acute decorticated cat]. (1966) (1)
From pregnancy to childhood and adulthood: the trajectory of hypertension. (2016) (1)
LB01.06: VISIT-TO-VISIT BLOOD PRESSURE VARIABILITY AND CARDIOVASCULAR OUTCOMES IN FELODIPINE EVENT REDUCTION STUDY (2015) (1)
Why a new calcium antagonist (1991) (1)
Obesity, diabetes, and antidiabetic treatment: blood pressure and vascular effects. (2016) (1)
Sympatho-renal interactions (1987) (1)
The phase space of 24 h values of RR interval and arterial blood pressure (2005) (1)
Advances in treatment strategies in hypertension: the very-low-dose combination first-line. (2001) (1)
[Significance of continuous monitoring of arterial blood pressure in the diagnosis of hypertension]. (1986) (1)
Hypertension : recent advances and research (1982) (1)
Outcomes with physician's choice of initial drug in convince (2004) (1)
[Increase of extension tonus by stereotaxic stimulation of the cerebellum]. (1953) (1)
Where do calcium antagonists fit in today's antihypertensive care? (1988) (1)
INTERVENTIONAL TRIALS IN HYPERTENSION: WHAT HAVE WE LEARNED AND WHAT REMAINS TO BE LEARNED? (2014) (1)
Angiotensin II receptor blockers and cardiovascular protection : Focus on left ventricular hypertrophy regression and atrial fi brillation prevention (2008) (1)
Interplay of sino-aortic reflexes and haemodynamic changes during natural sleep in the cat. (1976) (1)
Type A behaviour pattern and incidence of coronary heart disease in the Belgian Heart Disease Prevention Project (1985) (1)
Efficacy of aspirin in people with diabetes: an individual participant data meta-analysis of 26 randomised trials (2014) (1)
Time-course of the changes in blood pressure and in plasma renin activity during the first week after dilation of renal artery stenosis. (1989) (1)
Integrated care concepts with angiotensin-converting enzyme inhibition: intervention for life. Introduction. (1994) (1)
9C.01: WHICH RISK FACTORS ARE IMPORTANT FOR ENDPOINT CARDIOVASCULAR EVENTS IN THE FEVER STUDY? A PRACTICAL APPLICATION OF ROC CURVES IN CLINICAL TRIALS (2015) (1)
The approach to hypertension: from childhood to old age. (2016) (1)
High prevalence of retinal vascular changes in early phases of essential hypertension (1999) (1)
[Pyramidal and extrapyramidal mechanisms of hypertoxic convulsions]. (1954) (1)
Treatment Perspectives in Hypertension (1994) (1)
Where is hypertension research going (2007) (1)
Reading and citing from the Journal of Hypertension: an article listed as the top cited medical paper in 2003–2005 (2006) (1)
Overview and Perspectives of Antihypertensive Treatment (2012) (1)
The Journal of Hypertension: web visits and citations (2005) (1)
Predisposing factors, accompanying diseases and complications of hypertension. (2017) (1)
P-453 *Program Revision (see p. 267A): Gender specific characteristics of 15,288 hypertensive patients at high coronary risk. The value trial (2001) (1)
Influence of age and gender on preventing myocardial infarction by antihypertensive treatment and aspirin in the hot study. (1999) (1)
Two different hemodynamic patterns underlying hypotension during desynchronized sleep (1967) (1)
Buying news and buying judgement. (2013) (1)
[Distribution of responses evoked in the diencephalon by somatic stimulation]. (1961) (1)
Blood pressure response to treatment. (1983) (1)
The responses of adrenocorticotrophic hormone and cortisol to insulin-induced hypoglycaemic stress in man are unimpaired during chronic converting enzyme inhibition. (1985) (1)
Predictive, mechanistic, and therapeutic studies on hypertension and cardiovascular morbidity and mortality. (2014) (1)
[Arterial hypertension. Effectiveness and limitations of guanethidine therapy]. (1960) (1)
Reply to blood pressure target in chronic kidney disease. (2013) (1)
Time course of the changes in active and cryoactivatable renin in response to acute stimuli before and after diuretic therapy in man. (1982) (1)
P-241: Efficacy and tolerability of lercanidipine in elderly hypertensives: results of a multicenter, double-blind, randomized study (2002) (1)
Excitation of sham rage behaviour by controlled electrical stimulation of group I muscle afferents (1966) (1)
Effect on resting blood pressure and blood pressure homeostasis of short-term administration of the alpha1-adrenergic receptor antagonist, trimazosin, in hypertension (2005) (1)
Vasodilatation in hypertension: the relevance of ISA. Concluding paper. (1987) (1)
Preliminary Clinical Experience with Calcium Antagonists in Atherosclerosis (2012) (1)
Antihypertensive and Water and Sodium Balance Effects of Felodipine, A New Vasodilating Calcium Antagonist, in Hypertensive Patients (2012) (1)
Different effects of anti-hypertensive regimens based on fosinopril or hydrochlorothiazide with or without lipid lowering by pravastatin on progression of asymptomatic carotid arthrosclerosis. Principal results of PHYLLIS—A randomized double-blind trial (2005) (1)
The value trial: patients demographics and progress report. (1999) (1)
Excretory responses to renal nerve stimulation during inhibition of neutral metalloendopeptidase and angiotensin-converting enzyme in the rat. (1996) (1)
Consensus documents and challenges in hypertension research. (2016) (1)
Antihypertensive therapy: from 2003 to 2013 and beyond (2013) (1)
Coronary Hemodynamics Following Activation and Inhibition of the Renin‐Angiotensin System in Mild Hypertensive Patients (1987) (1)
Considerations on physiopathological approaches to the treatment of hypertension. (1978) (1)
Proceedings: Cardiovascular responses and renin release during stimulation of afferent renal nerves in the cat. (1975) (1)
Aspirin benefit increases as eGFR declines: Results from a randomised controlled trial in a hypertensive population (2010) (1)
2015 Supplement S1: Lercanidipine therapy: New experiences from Eastern Countries Lercanidipine in worldwide usage (2015) (1)
External validation of the MetS score, a prediction tool for metabolic syndrome. (2016) (1)
History of European hypertension guidelines. Definition and classification of hypertension and total cardiovascular risk (2008) (1)
A vascular protective concept in hypertension and heart failure. (1994) (1)
[Perindopril: first-line treatment of arterial hypertension]. (1989) (1)
70 Effect of exposure to high altitude on plasma endothelin-1 in man and its relationship to changes in pulmonary and systemic pressure (1993) (1)
Opening address of the President of the International Society of Hypertension. (1979) (1)
Hemodynamic patterns during fighting behaviour in the cat (1968) (1)
Haemodynamic effects of antihypertensive agents in man (1984) (1)
Clinical Practice and Guidelines in Europe for the Treatment of Hypertension, with a Focus on Patients with Diabetes Mellitus (2007) (1)
Treatment adherence and hypertension in the elderly. (2017) (1)
[Activity of preganglionic sympathetic single fibers during experimental coronary occlusion]. (1968) (1)
Round table 2 : World Health Organization-International Society of Hypertension versus United States guidelines on hypertension treatment : similarities and differences (1993) (1)
Calcium antagonists alone or in combination in today's antihypertensive therapy. (1988) (1)
Handbook of Hypertension - vol. 25 - Clinical Pharmacology and Therapeutics of Hypertension, editor G.T. McInnes - 2008, Elsevier B.V., Amsterdam (2008) (1)
What to look for in the current issue? (2013) (1)
Interview with Alberto Zanchetti, MD. (2005) (1)
Information, discernment and learning: for I am nothing if not critical. (2012) (1)
Cardiac and renal damage in the elderly hypertensive (2002) (1)
Methodological aspects: general discussion (1996) (1)
Role of socio-economic factors, blood pressure measurement, and therapeutic strategies in hypertension. (2015) (1)
Blood pressure measurement, blood vessels and treatment of hypertension. (2018) (1)
Position Paper: The Control of Renin Release (1981) (1)
SELF-REPORTED WEIGHT AND HEIGHT: IMPLICATIONS FOR LEFT VENTRICULAR HYPERTROPHY DETECTION. A MULTI-CENTER ITALIAN STUDY: PP.22.362 (2010) (1)
Reflex regulation of consciousness and emotional behaviour (2005) (1)
[Hemodynamic modifications during natural sleep in cats]. (1967) (1)
Nebivolol in Hypertension and Chronic Heart Failure (2006) (1)
The risk of hypertension: successes and failures of antihypertensive treatment. (1989) (1)
Lifestyle and therapeutic interventions for hypertension. (2015) (1)
Cardiovascular changes during spontaneous micturition in conscious cats. (1979) (1)
Targeting Hypertension with Valsartan: Lessons Learned from the Valsartan/HCTZ Versus Amlodipine in Stage II Hypertensive Patients (VAST) Trial (2006) (1)
Epidemiological, pathophysiological and therapeutic aspects of hypertension. (2017) (1)
Effect of Oral Dilevalol on Forearm Circulation in Essential Hypertension (1992) (1)
CHRONIC KIDNEY DYSFUNCTION BY OCCUPATIONS. RESULTS OF THE ICARIA STUDY: HT.3.02 (2010) (1)
[Effect of intensive antihypertensive treatment and of aspirin in a low dose in the hypertensive. The HOT (Hypertension Optimal Treatment) study]. (1999) (1)
Respiratory influences upon depressor and pressor responses to stimulation of the aortic nerve in the decerebrate cat (1964) (1)
[Electric stimulation of muscle afferents of group I in the acute decorticated cat]. (1966) (1)
Effect of sublingual captopril administration on left ventricular filling assessed by pulsed Doppler echocardiography in hypertensive patients (1997) (1)
Renin and Depression (1978) (1)
International conference on biomedical aspects of aging research (1998) (1)
Blood Pressure Variability , Carotid Atherosclerosis and Cardiovascular Events in the European Lacidipine Study on Atherosclerosis Running title : Mancia et al . ; Long-term BP variability and organ damage (2012) (1)
From dietary factors to drug adherence: approaches to improve understanding and treatment of hypertension. (2015) (1)
[Old and new approaches to preventing coronary disease with the therapy of hypertension]. (1984) (1)
Cardiac, renal and vascular complications in the diabetic patient (2000) (1)
From blood pressure measurement to treatment: the scope of hypertension research. (2018) (1)
Cardiovascular advantages of a third generation calcium antagonist. Symposium on lacidipine. Foreword. (1999) (1)
Perindopril/Indapamide (2012) (1)
Closing Remarks: Current Position of Calcium Channel Antagonists in Hypertension — the Role of Manidipine (2012) (1)
From pathophysiology to therapeutic interventions: the span of hypertension research. (2014) (1)
Plasma renin activity in primary and secondary depression (1977) (1)
Residual Risk in Treated Hypertension (2012) (1)
E096 The effect of losartan on left ventricular mass in hypertensive patients. Double blind comparison study with verapamil (1998) (1)
Evaluation of the 24 hours sympatho-vagal balance by the phase-space distribution of arterial blood pressure monitoring (ABPM) values (2006) (1)
Blood Pressure-Lowering Treatment and the Prevention of Heart Failure: Differences and Similarities of Antihypertensive Drug Classes (2019) (0)
[Effects of bilateral cervical vagotomy on the bradycardia and arterial hypertension of the natural sleep of the cat]. (1966) (0)
Guidelines, organ damage, diagnostic procedures and treatment. (2013) (0)
Drug Treatment in Liver Transplanted Patients: Antihypertensive Therapy (1993) (0)
[Central cardioinhibitor tonus and effect of atropine. III. Effect of prostigmine on atropine block of vagal inhibition]. (1950) (0)
Panel Discussion (1987) (0)
CENTRAL NERVOUS MECHANISMS IN CIRCULATION REGULATION. (1962) (0)
[The control of renin secretion: experimental data and clinical implications]. (1978) (0)
[Modifications of hyperoxic convulsions after pyramidal or extrapyramidal lesions]. (1953) (0)
Treating high blood pressure in the elderly: A challenge (2002) (0)
Challenges of antihypertensive treatment. (2016) (0)
Introductory remarks (1993) (0)
[Hypotensive and renin-stimulating action of captopril at first and during treatment with a beta-blocker]. (1982) (0)
Investigation clues for prognosis, diagnosis and therapeutic strategies. (2013) (0)
IMPROVEMENT OF PATIENTʼS KNOWLEDGE BY A SINGLE EDUCATIONAL MEETING ON HYPERTENSION: P1.25 (2000) (0)
[Which is the optimal pressure level to be obtained with antihypertensive treatment?]. (1994) (0)
One hundred years of blood pressure measurement: A tribute to Scipione Riva-Rocci (1996) (0)
[Effects of sulfhydryl-containing compounds on hyperoxic neuro-intoxication]. (1956) (0)
[Neurovegetative effects of stereotaxic stimulation of the cerebellum]. (1953) (0)
Focus on diagnostic and therapeutic aspects of hypertension. (2018) (0)
Atherosclerosis Assessment Confounders in the Rancho (2007) (0)
P-328: The effects of experimental acute renal hypertension on sympathetic nerve activity to the kidney in the rat (2002) (0)
Updating recommendations for prevention of coronary heart disease. (1998) (0)
Renal pathophysiology, arterial stiffness, and therapeutic approaches. (2017) (0)
[Local or remote origin of evoked diencephalic potentials recorded with monopolar and bipolar leads: experiments with localized lesions]. (1963) (0)
Editorial comment ACE inhibitors and cardioprotection (1989) (0)
Lercanidipine in worldwide usage (2015) (0)
INTENSIVE BLOOD PRESSURE LOWERING: CONTRAST BETWEEN BENEFITS IN DIABETICS AND OTHER GROUPS OF HYPERTENSIVE PATIENTS AND INCREASED RISK IN SMOKERS (2000) (0)
ME 02-2 BLOOD PRESSURE TARGETS IN CHRONIC KIDNEY DISEASES AFTER THE SPRINT TRIAL. (2016) (0)
Arterial Baroreflexes in Human Beings (1984) (0)
[Arterial pressure during natural sleep in the cat before and after interruption of the sympathetic and parasympatetic innervation of the heart]. (1967) (0)
Electrolyte balance during treatment of arterial hypertension with diuretic drugs. (1973) (0)
Target blood pressure in elderly hypertensive patients: how low should you go? (2000) (0)
[Action of cerebellar lobus anterior and of the inhibitory reticular substance on postural tonus and on phasic reflexes, in absence and in presence of barbiturate narcosis]. (1953) (0)
[Clinical pharmacology of a new hypotensive drug with peripheral vasodilating action (ISF 2123); effects of acute intravenous administration in hypertensive patients]. (1977) (0)
[Microelectrodic analysis of regions of the pontine reticular substance of prevalent ascending or descending projection]. (1956) (0)
[A case of juvenile arterial hypertension associated with hypokalemia and low aldosterone secretion (Liddle syndrome)]. (1968) (0)
From blood pressure measurement to antihypertensive treatment. (2015) (0)
[Hemodynamic changes during sleep in animals with intact sympathetic system and in sympathetectomized animals]. (1968) (0)
[Reflex inhibition of the characteristics of pseudorabies in acute thalamic cats]. (1960) (0)
J. D. Swales (editor), Platt versus Pickering: an episode in recent medical history, London, Keynes Press (British Medical Association), 1985, 8vo, pp. [vii], 155, illus., £45.00. (1986) (0)
[Left ventricular function in convalescent subjects with myocardial infarct: effects of ouabain]. (1975) (0)
[Clinical aspects of the neurogenic control of circulation in arterial hypertension]. (1979) (0)
Early endogenous neurogenesis activation in stroke-prone spontaneously hypertensive rat (SHRSP) precedes ischaemic events (2009) (0)
[Hemodynamic changes during fighting behavior in cats. II. Fighting in lying-down position]. (1968) (0)
[Effects of electrical stimulation of the aortic nerve in acute thalamic cats]. (1963) (0)
Dissociation of the effects of alpha 1-adrenergic blockade on blood pressure and renin release in patients with essential hypertension. (1982) (0)
Introduction. Why a new calcium antagonist? (1991) (0)
5.5 Prevalence and Correlates of Multiple Organ Damage in Treated Hypertensives: Results From the ETODH Study (2008) (0)
Cardiopulmonary origin of vagal afferent fibers exerting a tonic reflex influence on the circulation (1962) (0)
[Therapy of arterial hypertension: benefits, costs, challenges]. (1996) (0)
[Reflex tachycardia caused by administration of mecholyl in normotensive and essential hypertensive patients]. (1962) (0)
[Hemodynamic mechanisms of arterial hypotension present during desynchoronized sleep in the cat]. (1967) (0)
Concluding remarks (1988) (0)
[Effect of prostigmine on atropine block of vagal inhibition]. (1951) (0)
Recommendations for practice and mechanistic investigations. (2014) (0)
Obesity and other aspects of hypertension. (2015) (0)
[Excretory activity of a new saluretic derivative: hydrochlorothiazide and its comparison with chlorothiazide]. (1959) (0)
Problems of antihypertensive management: diabetes mellitus, ethnic differences, organ damage and resistance to treatment. (2017) (0)
Baroreceptor mechanisms and the control of vascular resistance (1989) (0)
in Stage II Hypertensive Patients (VAST) Trial Targeting Hypertension with Valsartan: Lessons Learned from the Valsartan/HCTZ Versus Amlodipine (2013) (0)
[Excitatory action of the chemoreceptive afferents on the posterior hypothalamus in the acute thalamic cat]. (1960) (0)
Are There Markers for the Physiopathology of Essential Hypertension (1984) (0)
[Hypertension and cardiovascular damage]. (1992) (0)
[Effects of mesencephalic lesions on the reactions of false rabies induced by stimulation of the lateral hypothalamus in acute thalamic cats]. (1963) (0)
4.5 Prevalence and Clinical Correlates of Multiple Organ Damage in a Never Treated Hypertensive Population (2007) (0)
Prediction, diagnosis and treatment of hypertension. (2016) (0)
[Alpha-methyldopa and neural control of the circulation in essential hypertension]. (1980) (0)
1.8 Impact of Overweight on Nocturnal Blood Pressure Patterns in Untreated Essential Hypertensives (2007) (0)
Efficacy of Antihypertensive Treatment for Stroke Prevention. (1994) (0)
Treatment of hypertension in the elderly. (1998) (0)
Obituary – Björn Folkow (2012) (0)
In Memoriam Alberto Zanchetti (Parma July 27, 1926–Milan March 24, 2018) (2018) (0)
MEDICE CURA TE IPSUM: CARDIOVASCULAR RISK AND CONTROL AMONG PHYSICIANS IN SPAIN: LB3.3 (2011) (0)
Atenolol: Once-daily treatment of hypertension (1982) (0)
4.4 Ambulatory Heart Rate and Target Organ Damage in Never Treated Essential Hypertensives (2007) (0)
[Stimulation at various rhythms of different groups of cutaneous fibers in the acute thalamic cat]. (1964) (0)
Possible role of the sympathetic nervous system in the pathogenesis of hypertension. (1985) (0)
37 Superiority of acceleration time as ultrasonographic index for detecting renal artery stenosis (1993) (0)
RELATIONSHIP BETWEEN SICK LEAVE, RISK FACTORS AND GLOBAL CARDIOVASCULAR RISK AND ITS ECONOMIC IMPACT. STUDY ICARIA 2004-2007: HT.3.01 (2010) (0)
[Effect of anoxic stimulation of the chemoceptors on vagal respiratory reflexes]. (1951) (0)
L'insufficienza cardiocircolatoria (1957) (0)
Contents, Vol. 80, 1992 (1992) (0)
P-63: Evolution of blood pressure control in selected hypertensives followed in a hypertension outpatient clinic (2001) (0)
[Effects of total sympathectomy on hemodynamic changes in desynchronized sleep]. (1968) (0)
Antihypertensive therapy: problems and perspectives. (1986) (0)
[Relation between inhibitory effects of cerebellum and bulbar reticular substance]. (1953) (0)
[Changes in arterial pressure during sleep in animals with experimental renal hypertension]. (1966) (0)
[Role of angiotensin converting enzyme inhibitors in the therapy of hypertension]. (1986) (0)
Renal Function in Hypertensive Patients and Calcium Entry Blockers (1988) (0)
Hypertension and the Heart (1997) (0)
Blood vessels and the kidney in hypertension. (2017) (0)
Epidemiological, pathophysiological and therapeutic aspects of hypertension. (2017) (0)
576 HOW PROMPT AND HOW LASTING ARE THE BENEFICIAL EFFECTS OF ANTIHYPERTENSIVE TREATMENT ON OUTCOMES? POST-HOC ANALYSES OF RANDOMIZED CONTROLLED TRIALS (2012) (0)
Ambulatory Blood Pressure, Target Organ Damage and Left Atrial Size in Never Treated Essential Hypertensives: 2.8 (2005) (0)
PP.28.24: INTEGRATIVE DATA ANALYSIS IN THE INGENIOUS HYPERCARE COHORT (2015) (0)
[Current events in physiopathology; dyspnea]. (1957) (0)
Diagnostic and therapeutic aspects of hypertension : proceedings of a symposium held in Nice, France, January 29-30, 1993 (1994) (0)
[On the intra-thoracic origin of the "extra-aortic" vagal afferent fibers participating in the tonic regulation of arterial pressure]. (1961) (0)
SP045A PROTEO-BIOSTATISTIC APPROACH FOR FINDING THE UNDERLYING MOLECULAR DETERMINANTS OF HYPERTENSION (2017) (0)
SEASONAL INFLUENCES ON AMBULATORY BLOOD PRESSURE. AN INSIGHT FROM THE HARVEST STUDY. AUTHORS' REPLY (1999) (0)
The HOT study—further analyses (2000) (0)
Introduction: advances in the prevention of cardiovascular disease in patients with diabetes. (2008) (0)
BENEFITS OF ANTIHYPERTENSIVE TREATMENT IN UNCOMPLICATED HYPERTENSION: DATA OF THE FEVER STUDY: 6A.05 (2010) (0)
[Neural mechanisms of emotional behavior]. (1966) (0)
ISVH Society September Newsletter (2007) (0)
[Cerebellum and increase of extensorial tonus]. (1954) (0)
[Hypotensive and renin-stimulating action of captopril before and during treatment with beta-blockers]. (1982) (0)
A NEW SENSITIVE APPROACH FOR THE ASSESSMENT OF J-CURVE FINDINGS FROM THE FEVER TRIAL: LB2.3 (2011) (0)
[The pneumatic collar in the study of the human carotid baroreceptor reflex]. (1976) (0)
A Vascular Protective Concept in Hypertension and (1994) (0)
[Pharmacodynamics and clinical aspects of hydrochlorothiazide]. (1961) (0)
Dietary, clinical and therapeutic aspects of hypertension. (2016) (0)
[Pressor effects of the reintegration of the potassium reserve in hypertensive patients during hypotensive treatment with saluretics]. (1961) (0)
[Latin American consensus on hypertension in patients with diabetes type 2 and metabolic syndrome]. (2014) (0)
Blood pressure and opera (2013) (0)
[Variability of arterial blood pressure: importance, mechanisms and clinical significance]. (1988) (0)
Address on the Occasion of the Official Dinner at the Seventh Meeting of the International Society of Hypertension by the President (1979) (0)
Subject Index, Vol. 6 (Suppl. 2), 1986 (1986) (0)
[Systolic cardiac output and minute-volume during natural sleep in the cat. Preliminary research with implanted electromagnetic flowmeters]. (1966) (0)
Opening remarks (1987) (0)
European GWAS strategy using extremes of blood pressure distribution (2009) (0)
From the monitoring of severe to a survey of mild adverse effects of current antihypertensive therapy: the hidden side of the iceberg. The Scientific Committee of the Italian Pharmacoepidemiology Survey on Antihypertensive Therapy. (1997) (0)
Manidipine of its Use in the Management of Hypertension (2004) (0)
ACE inhibitors and cardioprotection. (1989) (0)
G036: The impact of different echocardiographic and ultrasonographic diagnostic criteria on the prevalence of left ventricular and carotid hypertrophy in a selected hypertensive population (2000) (0)
Computeranalysis of cardiovascular signals. (1995) (0)
Oral Sessions (2009) (0)
E095: Does the clinic blood pressure measurement overestimate blood pressure control in treated hypertensive patients? (1998) (0)
Sympathorenal Interactions in the Control of Cardiovascular Functions (1990) (0)
METHODOLOGICAL ASPECTS : GENERAL DISCUSSION. DISCUSSION (1996) (0)
H007: An experimental acute angiotensin-mediated renal hypertension (2000) (0)
Why a new calcium antagonist ? Discussion (1991) (0)
[Use of lasers in arterial revascularization]. (1986) (0)
The hypertension optimal study (1998) (0)
[Carotid sinus reflexes in the acute thalamic cat]. (1959) (0)
Recent Advances in Beta Blockade: Therapeutic Implications in Hypertension 1st International Symposium on Tertatolol, Milano, June 1985: Proceedings (1986) (0)
[Behavior of false rage in the decorticate cat after interruption of the pathways of ascending projection to the hypothalamus]. (1961) (0)
Buying news andbuying judgement (2012) (0)
Role of the renal nerves in the response by atrial natriuretic factor to acute volume expansion. (1991) (0)
Consensus Document European Society of Hypertension practice guidelines for ambulatory blood pressuremonitoring (2014) (0)
1.3 Reproducibility of Dipping/Non Dipping Pattern in Untreated Essential Hypertensives: Impact of Gender and Age (2007) (0)
[LESIONS OF THE MESENCEPHALO-LIMBIC PATHWAYS AND THEIR EFFECT ON ELECTROENCEPHALOGRAMS DURING DEEP SLEEP IN CATS]. (1963) (0)
AN EXPERIMENTAL ACUTE HYPERTENSION DUE TO THE ACTIVATION OF THE RENAL RENIN-ANGIOTENSIN SYSTEM IN THE RAT: P2.162 (2000) (0)
OUTCOMES IN PATIENTS NOT RECEIVING ADD-ON THERAPY IN THE STUDY ON COGNITION AND PROGNOSIS IN THE ELDERLY (SCOPE): 6A.3 (2004) (0)
[Modifications, during Berger's arrest reaction, of the convulsive activity produced by the local application of strychnine on the cerebral cortex of the rabbit]. (1952) (0)
Blood pressure and LDL-cholesterol targets for prevention of recurrent strokes and cognitive decline in the hypertensive patient: design of the European Society of Hypertension^Chinese Hypertension League Stroke in Hypertension OptimalTreatment randomized trial (2014) (0)
Editorial: The challenge to treat hypertensive patients with type 2 diabetes (2003) (0)
CARDIOVASCULAR RISK STRATIFICATION ACCORDING TO THE 2003 ESH-ESC GUIDELINES IN PATIENTS WITH ESSENTIAL HYPERTENSION: COMPARISON WITH THE 1999 WHO/ISH GUIDELINES (2004) (0)
Stepped-Care Versus Individualized Antihypertensive Treatment in the 1990’s (1992) (0)
A look at differences: hypertension in the world. (2014) (0)
OS 14-01 AN ESTIMATED OPTIMAL HYPERTENSION LEVEL OF GOALS ON DRUG THERAPY FROM THE FEVER TRIAL (2016) (0)
[Cortical interference between augment potentials and recruitment potentials]. (1955) (0)
51. Antihypertensive and metabolic effects of slow-release nicardipine in diabetic hypertensive patients (1991) (0)
Ambulatory blood pressure monitoring, arterial function and other problems concerning hypertension. (2013) (0)
Foreword (2011) (0)
RenalAfferents Signaling Diuretic Activity intheCat (1993) (0)
Blood pressure measurements, patterns, and targets. (2017) (0)
The Phase space of arterial blood pressure monitoring (2005) (0)
[Cardiocirculatory insufficiency. II. Cardiac reserve in heart diseases]. (1958) (0)
Investigating multiple aspects of blood pressure control. (2014) (0)
Concept of Antihypertensive Treatment in the Elderly (1989) (0)
Aortic coarctation suspected by echo-doppler of renal arteries in hypertensive patients referred to a hospital out-patient hypertension clinic (2005) (0)
[Effect of d-tubocurarine on the motor cortex of mammals]. (1950) (0)
Predictive medicine, pathophysiology and therapeutics. (2014) (0)
EFFECTS OF SINGLE OR MULTIPLE DRUG THERAPIES ON CARDIOVASCULAR OUTCOMES IN HYPERTENSION: ANALYSIS OF DATA FROM THE VALUE TRIAL: 6C.04 (2011) (0)
COST-EFFECTIVENESS CALCULATIONS FROM TRIALS. DISUCUSSION (1996) (0)
P-324: An experimental acute angiotensin-mediated renal hypertension in the rat (2001) (0)
Oral Sessions (2012) (0)
E003: Effect of mono- and bilateral nephrectomy on efferent sympathetic nerve activity to the kidneys in the rat (2000) (0)
The metabolic syndrome and antihypertensive treatment in the European Lacidipine Study on Atherosclerosis (ELSA) (2005) (0)
7.4 Lack of Association between Serum Uric Acid and Organ Damage in a Never Treated Essential Hypertensive Population at Low Prevalence of Hyperuricaemia (2007) (0)
[Electro encephalographic aspects of hypertoxic convulsive syndrome]. (1954) (0)
[Neural mechanisms in arterial hypertension]. (1982) (0)
D012 Valsartan antihypertensive longterm use evaluation (the value study) (1998) (0)
[Overcoming of atropine block by increase of frequency of the cardioinhibitor impulses]. (1951) (0)
[Pressure changes during deep sleep in the cat with deafferentation of the carotid and aortic sinuses]. (1964) (0)
New European studies on atherosclerosis in hypertension (1995) (0)
Regulation of vasopressin secretion after administration of sodium nitroprusside in hypertensives. (1991) (0)
Expression of concern (2018) (0)
[Functional aspects of respiratory pathology. II. Pulmonary circulation and its relations with alveolar ventilation]. (1957) (0)
[Neural and endocrine mechanisms in the genesis of hypothalamic hypertension]. (1950) (0)
How should elderly hypertensive patients be treated? : proceedings of Satellite Symposium to the 12th Scientific Meeting of the International Society of Hypertension, May 1988, Kyoto, Japan (1989) (0)
[Stimulation of thalamic nuclei with specific projection and cortical excitation]. (1955) (0)
[Electroencephalography and behavior of cats after pontine section]. (1957) (0)
New evidence and critical reappraisal of available evidence: the task of a scientific journal. (2015) (0)
[Effects of stimulation of the bulbo-pontile tegmentum in the acute thalamic cat]. (1960) (0)
ANTIHYPERTENSIVE EFFICACY AND SAFETY OF OLMESARTAN MEDOXOMIL AND RAMIPRIL IN ELDERLY PATIENTS WITH MILD TO MODERATE ESSENTIAL HYPERTENSION: THE ESPORT STUDY: HT.1.03 (2010) (0)
Prediction and prevention of hypertension-related events. (2016) (0)
Focus on clinical problems. (2014) (0)
[Arterial hypertension. Research, progress, hypotheses in the 1970's]. (1981) (0)
[Dyshomogeneity of the response of cryoactive renin to orthostatism in normotensive and essential hypertensive patients]. (1982) (0)
Round table discussion: what blood pressure to measure? (1991) (0)
VALUE OF ECHOCARDIOGRAPHIC AND AMBULATORY BLOOD PRESSURE (1989) (0)
[Overcoming atropine block by increase of number of active cardioinhibitory fibers]. (1951) (0)
[Round table on Hypertension and coronary heart disease: new trends in treatment]. (1984) (0)
Studying arterial wall in hypertension. (2015) (0)
[Physiopathological and clinical approaches to the treatment of hypertension (author's transl)]. (1979) (0)
Hypertension: Concluding remarks (1990) (0)
[Latin American consensus on hypertension in patients with diabetes type 2 and metabolic syndrome]. (2014) (0)
PRELIMINARY BASELINE DATA OF HYPERTENSIVE PATIENTS INCLUDED IN THE CATCH (CANDESARTAN ASSESSMENT IN THE TREATMENT OF CARDIAC HYPERTROPHY) STUDY: P1.195 (2000) (0)
[Ventricular repolarization in the spatial electrocardiogram in arterial hypertension]. (1959) (0)
Guidelines, position studies, and blood vessel research. (2017) (0)
Behavioural stress blunts the creatinine clearance increase induced by a protein load in healthy subjects. (2001) (0)
[Modifications of strychnine clonus and epilepsy caused by intense electrical stimulation by pyramidal & extrapyramidal lesions]. (1953) (0)
Subject Index, Vol. 83, 1993 (1993) (0)
[Pyramidal and extrapyramidal aspects of strychnine clonus and of faradic epilepsy]. (1954) (0)
Subject Index, Vol. 80, 1992 (1992) (0)
Regulation of circulation by carotid sinus, aortic and cardiopulmonary receptors (1966) (0)
Central command and reflex regulation: Cardiovascular patterns during behavior (1986) (0)
Metabolic syndrome and biventricular hypertrophy in essential hypertension. Commentary (2009) (0)
[Effects of mesencephalic lesions on sham rage behavior in the acute thalamic cat]. (1960) (0)
PO23-744 PROJECTED PERCENT LDL-C REDUCTION & NCEP-III CHOLESTEROL GOAL ATTAINMENT WITH EZETIMIBE/SIMVASTATIN IN A COHORT OF GUBBIO PATIENTS NOT AT GOAL ON STATIN MONOTHERAPY (2007) (0)
Analysis of the time course of renal vascular and excretory responses to electrical stimulation of the renal efferent nerves (1992) (0)
[The tolerability of antihypertensive therapy: limits and dimensions of a summary phenomenon]. (1997) (0)
Intervention of Single Risk Factor: Hypertension (1983) (0)
Translating worldwide calcium‐channel blocker experience into clinical practice (2003) (0)
P-660: Cardiovascular risk stratification in hypertension: Impact of left ventricular hypertrophy diagnosed by different echocardiographic criteria (2001) (0)
From inflammation to renal denervation in hypertension research. (2016) (0)
CHANGES IN CAROTID WALL COMPOSITION FOLLOWING ANTIHYPERTENSIVE TREATMENT: DATA FROM THE ELSA SUBSTUDY ON ECHOREFLECTIVITY (2004) (0)
[Do pathophysiological markers of essential hypertension exist?]. (1982) (0)
Advances in beta-blocker therapy II : proceedings of the 2nd international symposium, Venice, October 16-17, 1981 (1982) (0)
Association BetweenMore Intensive vs Less Intensive Blood Pressure Lowering and Risk ofMortality in Chronic Kidney Disease Stages 3 to 5 A Systematic Review andMeta-analysis (2017) (0)
[Hemodynamic changes during fighting behavior. IV. Prolonged struggling]. (1969) (0)
Antiatherosclerotic effects of calcium antagonists in man: Presentation of the VHAS study (1992) (0)
Seventeenth Scientific Meeting on Hypertension, Amsterdam, The Netherlands, 7-11 June 1998: Foreword (1998) (0)
[Selective abolition of sino-carotid baroceptive reflexes and arterial pressure during the natural sleep of the cat]. (1966) (0)
The Protective Cardiovascular Effects of Antihypertensive Treatment (2019) (0)
Contents Vol. 83, 1993 (1993) (0)
Introduction. Hypertension in patients with diabetes: can the treatment of macro and microvascular events be improved? Rational of the ADVANCE Study (2006) (0)
[Duration of the hippocampal theta rhythm during deep sleep in the cat, after lesions of the mesencephalo-limbic system]. (1964) (0)
Book Reviews / Personalia (1955) (0)
Editor's Corner: a look at current hypertension research from this issue content. (2013) (0)
Characteristics of an ideal antihypertensive therapy for elderly hypertensives. (1995) (0)
Contributions to management of hypertension from papers in the current issue. (2013) (0)
Protein Intake and Kidney Function in the Population: Differences inCross-Sectional and Longitudinal Data (2013) (0)
Nadolol prevents the exercise-induced rise in lymphocyte beta-receptor number in borderline hypertension. (1989) (0)
Dietary and metabolic aspects of hypertension and hypertension-related organ damage. (2015) (0)
Proceedings of the Sixth Meeting of the International Society of Hypertension, Göteborg, Sweden, 11-13 June 1979. (1979) (0)
[Regional hemodynamics during desynchronized sleep in the cat]. (1968) (0)
[Pathogenesis of experimental renal hypertension]. (1952) (0)
Fixed-Dose Combination Enalapril/ Nitrendipine of its Use in Mild-to-Moderate Hypertension (2004) (0)
[Functional aspect of respiratory pathology. III. Mechanism of respiration]. (1957) (0)
Blood Pressure Lowering and Risk of Mortality in Chronic Kidney Disease: A Meta2 Analysis of Randomized Controlled Trials (2018) (0)
EFFECTS OF INDIVIDUAL RISK FACTORS ON THE RESIDUAL RISK OF CARDIOVASCULAR EVENTS IN A POPULATION OF TREATED CHINESE PATIENTS WITH HYPERTENSION. DATA FROM THE FEVER STUDY: PP.16.92 (2010) (0)
Fourth European Meeting on Hypertension Opening Address (1989) (0)
Estimation of metabolic syndrome heritability in three large populations including full pedigree and genomic information (2019) (0)
News, Reminiscences and Perspectives: a new section of the Journal of Hypertension (2002) (0)
What really matters is not what the authors meant to say, it is how their work is read. (2013) (0)
[On a method for ascertaining the local or remote origin of evoked potentials in deep cerebral structures]. (1966) (0)
[Hemodynamics of the emotional behavior of the cat]. (1969) (0)
Pathophysiological mechanisms of myocardial stunning in humans (1996) (0)
7.3 Association of Organ Damage with the Metabolic Syndrome (MS) as Diagnosed in Hypertension and Lipid Clinics: The PROMISE Survey (2007) (0)
Monitoring Blood Pressure in Patients with Acute Stroke (2003) (0)
Intermediate cardiovascular end points in therapeutic trials (1997) (0)
Reliability of Blood Pressure Patterns Defined by a Single 24-Hour Ambulatory Blood Pressure Monitoring: The Case of the Dipping/Non Dipping and Isolated Clinic Hypertension (2007) (0)
From the pathophysiological to the epidemiological approach to hypertension research. (2015) (0)
[Central cardio-inhibitor tonus and effect of atropine. II. Counteraction of atropine block obtained by means of increase of the number of active cardio-inhibitor fibers]. (1950) (0)
[Functional organization of the hypothalamic center inhibiting the sympathetic nervous system. I. Sympathetic and vagal mechanisms of the bradycardial effect and relationship with sino-aortic reflexes]. (1976) (0)
[Hemodynamic changes during fighting behavior in cats. I. Fighting in erect posture]. (1968) (0)
First-Line Treatment in Hypertension (2012) (0)
Volume contents (2002) (0)
STROKE REDUCTION WITH CANDESARTAN BASED THERAPY IN THE SCOPE STUDY - OUTCOMES IN PATIENTS BY BASELINE CHARACTERISTICS: P2.328 (2004) (0)
[Functional aspects of respiratory pathology]. (1957) (0)
Pathophysiological mechanisms of myocardial stunning (1996) (0)
Welcome by the Chairman of the Organizing Committee (1981) (0)
[EFFECTS OF PULMONARY VENTILATION ON PRESSOR RESPONSES TO ELECTRIC STIMULATION OF THE AORTIC NERVE IN DECEREBRATE CATS]. (1963) (0)
[Reflex influences on renal secretion of renin in essential hypertension]. (1977) (0)
130. Acute effect of cilazapril on coronary circulation in patients with renovascular hypertension (1991) (0)
ME 02-2 BLOOD PRESSURE TARGETS IN CHRONIC KIDNEY DISEASES AFTER THE SPRINT TRIAL. (2016) (0)
[Selective abolition of sino-carotid chemoceptive reflexes and arterial pressure during the natural sleep of the cat]. (1966) (0)
[Hemodynamic changes during fighting behavior in cats. 3. Preparation for the fight]. (1968) (0)
Arterial Baroreflexes in Normotensive and Hypertensive Man (1982) (0)
Large and small vessel disease and other aspects of hypertension. (2015) (0)
BRAIN STEM SYSTEMS AND BEHAVIOR. (1967) (0)
381 HIGHER CARDIOVASCULAR RISK AND IMPAIRED BENEFIT OF ANTIHYPERTENSIVE TREATMENT IN HYPERTENSIVE PATIENTS REQUIRING ADDITIONAL DRUGS ON TOP OF RANDOMIZED THERAPY. IS ADDING DRUGS ALWAYS BENEFICIAL? (2012) (0)
PREVALENCE OF BLOOD PRESSURE SELF-MEASUREMENT AND ITS RELATIONSHIP WITH BLOOD PRESSURE CONTROL IN A LARGE SELECTED HYPERTENSIVE POPULATION. A PROSPECTIVE OBSERVATIONAL STUDY: OP 056 (2004) (0)
Diagnostic and therapeutic approaches to hypertension. (2017) (0)
[Cardiovascular insufficiency]. (1957) (0)
[Hypotensive action of clonidine and baroreceptor reflexes in essential hypertension]. (1977) (0)
[Evaluation of sympathetic nervous activity in humans]. (1990) (0)
LOSARTAN (L) BUT NOT ATENOLOL (A) REDUCES AN INDEX OF CARDIAC FIBROSIS IN HYPERTENSIVE PATIENTS WITH LEFT VENTRICULAR HYPERTROPHY (LVH): A LIFE SUBSTUDY: PP.22.352 (2010) (0)
Osmoregulation of vasopressin during acute lowering of arterial pressure by clonidine in moderate hypertension. (1989) (0)
P-225: Predictors of one year blood pressure control and treatment resistance in the value trial (2002) (0)
2663 – SIMULTANEOUS ASSESSMENT OF CENTRAL AND PERIPHERAL EFFECTS OF A DRUG (1978) (0)
Perindopril/indapamide. A viewpoint (1999) (0)
EFFECT OF BASELINE COGNITIVE FUNCTION ON OUTCOMES IN THE STUDY ON COGNITION AND PROGNOSIS IN THE ELDERLY (SCOPE): 6A.5 (2004) (0)
[Pulmonary cardiopathy]. (1957) (0)
Effect of beta-adrenergic blockade on the changes in atrial natriuretic factor induced by acute volume depletion. (1991) (0)
A vascular protective concept in hypertension and heart failure. Proceedings of the 4th International Symposium on Cilazapril. Istanbul, Turkey, November 25-27, 1993. (1994) (0)
[Dyshomogeneity of responses of cryo-activated renin to orthostatism in normotensive subjects and those with essential hypertension]. (1982) (0)
What Is New and What Is Different in Recent Guidelines on Antihypertensive Treatment? Looking Forward to Guidelines Reappraisal (2018) (0)
The Use of Calcium Antagonists in the Treatment of Arterial Hypertension (1985) (0)
Gajjala, P. R. et al. (2017) Proteomic-biostatistic integrated approach for finding the underlying molecular determinants of hypertension in human (2017) (0)
Design of the Syst-Eur trial and Syst-Eur Phase 2: Thomas Weihrauch's contributions. (2004) (0)
Heart Rate, Stroke Volume and Vasomotor Regulation in the Cat during Exertion and Postural Changes * (1970) (0)
Influence of urapidil and other antihypertensive agents on lipids and glucose metabolism in hypertensive patients. (1992) (0)
Labetalol plus chlorthalidone in a fixed combination (RG 136) : a rational approach to antihypertensive therapy (1984) (0)
[Hyperoxic neurointoxication: its prevention by drugs and study of its mechanisms]. (1958) (0)
Panel discussion among Drs Glasser, Mulcahy, Muller, Opie, White and Zanchetti (1998) (0)
PRIMARY PREVENTION OF CORONARY HEART DISEASE IN HYPERTENSION. DISCUSSION (1996) (0)
[Changes in arterial pressure during sleep in animals with experimental renal hypertension, before and after sino-aortic deafferentation]. (1966) (0)
[Selective lesions of various hypothalamic structures and spontaneous and pseudorabies behavior of the acute decorticated cat]. (1966) (0)
[The convulsive activity produced by local application of strychnine on the cerebral cortex of the rabbit and its modifications during Berger's arrest reaction]. (1951) (0)
Rho-kinase in the pathogenesis of cardiovascular inflammation and remodeling induced by long-term blockade of nitric oxide (2005) (0)
[Hemodynamic changes during muscular exercise in cats]. (1969) (0)
Hypertension and the heart. Advances in experimental medicine and biology (1997) (0)
Alberto Zanchetti and Costas Thomopoulos Be Lowered ? Benefits and Risks of Antihypertensive Treatment : How Far Can Diastolic Blood Pressure (2017) (0)
[OP.LB01.03] BENEFITS OF EARLY BLOOD PRESSURE CONTROL ON CARDIOVASCULAR OUTCOMES: A SUBGROUP ANALYSIS OF THE FELODIPINE EVENT REDUCTION (FEVER) STUDY (2016) (0)
Relationships of Framingham - defined cardiovascular disease events, major cardiovascular events and cardiovascular death in trials of antihypertensive treatment. (2013) (0)
REPRODUCIBILITY OF NOCTURNAL BLOOD PRESSURE FALL IN EARLY PHASES OF UNTREATED ESSENTIAL HYPERTENSION: PROSPECTIVE OBSERVATIONAL STUDY (2004) (0)
Facets of hypertension research. (2013) (0)
[Functional organization of the hypothalamic center inhibiting the sympathetic nervous system. II. Characteristics of vasodilation in the iliac, mesenteric and renal region]. (1976) (0)
Factors in the choice of beta-blocker vs. diuretic for initial treatment of hypertension in convince (2004) (0)
[Test methods for the diagnosis of renovascular hypertension]. (1967) (0)
From Parma to Pisa: building a great physiological institute (2011) (0)
[Noradrenalytic mechanism of hypothalamic hypertension]. (1952) (0)
HERITABILITY OF BLOOD PRESSURE (BP) PHENOTYPES IN EXTENDED PEDIGREES FROM THE GUBBIO POPULATION STUDY: PRELIMINARY RESULTS: LB1.2 (2011) (0)
HIGHER CARDIOVASCULAR (CV) RISK OF HYPERTENSIVE PATIENTS REQUIRING ADD-ON THERAPY IN THE FELODIPINE EVENT REDUCTION (FEVER) RANDOMIZED TRIAL: 6C.03 (2011) (0)
Last Letter from the President (1980) (0)
[Hypertensive cardiopathy in old age]. (1969) (0)
New Challenges in the Treatment of Hypertension, The Global Approach. Proceedings of the 2nd International Mediterranean Symposium on Hypertension. Lisbon, Portugal, 25-28 March 1993. (1993) (0)
COMPARISON OF PLASMA LEVELS OF NATRIURETIC PEPTIDES IN MINERALOCORTICOID AND GLUCOCORTICOID HYPERTENSION IN HUMANS: 5B.4 (2000) (0)
Postgraduate medical education: organization and aims. Italy. (1973) (0)
Hypertension-related organ damage and cardiovascular risk. (2014) (0)
Journal of Hypertension. Introduction. (2007) (0)
Target organ damage in hypertension. (1995) (0)
hypertensive subjects Carotid sinus baroreceptor control of arterial pressure in renovascular (2011) (0)
Calcium Antagonists in Combination Therapy (1989) (0)
[Neural influences on the renal secretion of renin: effects of phenoxybenzamine and propranolol]. (1973) (0)
[Further research on the prevention of hyperoxic epilepsy by means of drugs]. (1957) (0)
[Relation between the hypotensive and renin-stimulating effect of diuretic therapy in hypertensive patients]. (1978) (0)
Introduction (1994) (0)
Regulation of sodium and water excretions by neural renorenal reflexes in the cat. (1984) (0)
[Determination of plasma renin activity in the renal veins in essential arterial and nephrovascular hypertension: effect of trimethaphan infusion]. (1975) (0)
[Effect of the long-term administration of verapamil on arterial pressure and water-salt balance in hypertensive patients]. (1978) (0)
Borderline hypertension: the nature of the problem. (1986) (0)
Comparison Between Central and Peripheral Pulse Pressure as Determinants of Intermediate Cardiovascular Phenotypes (2011) (0)
Recommendations for practice andmechanistic investigations (2014) (0)
Vasodilating properties of dilevalol (1989) (0)
[Functional aspects of respiratory pathology. V. Cyanosis]. (1957) (0)
CLINIC AND 24 H LONG-TERM BLOOD PRESSURE (BP) VARIABILITY IN NON BETA-BLOCKER AND BETA-BLOCKER-TREATED HYPERTENSIVE PATIENTS. DATA FROM ELSA TRIAL: 6C.08 (2011) (0)
[Central cardio-inhibitor tonus and effect of atropine. I. Counteraction of atropine block produced by an increase of the frequency of the cardio-inhibitor impulses]. (1950) (0)
Cardiovascular Considerations in Hypertension - Effects of the Angiotensin System - Discussion (1990) (0)
[Effects of vagotomy on the renal secretion of renin in cats]. (1977) (0)
Safety Profile of Lacidipine (2012) (0)
[Electroencephalographic observations on cats with hyperoxic convulsions]. (1953) (0)
Optimal Blood Pressure in the Hypertensive Patient and the J-Curve Dilemma (2010) (0)
[Objectives and methods in therapy of essential arterial hypertension]. (1968) (0)
Dr Lowe has received funding for investigator-initiated (2002) (0)
[Neural mechanisms in emotional behavior]. (1966) (0)
Glaxo lecture: old and new concepts in the treatment of hypertension. (1993) (0)
[Tonic participation of extra-aortic vagal afferents in the regulation of arterial pressure in the cat]. (1960) (0)
VASOPEPTIDASE-INHIBITOR OMAPATRILAT (1999) (0)
An outlook on the content of this journal issue. (2013) (0)
Mechanisms, diagnosis and therapy of hypertension. (2018) (0)
D7 - The “hot” study; a large international prospective trial to evaluate the “J” curve during treatment of hypertension (1995) (0)
OS 14-01 AN ESTIMATED OPTIMAL HYPERTENSION LEVEL OF GOALS ON DRUG THERAPY FROM THE FEVER TRIAL. (2016) (0)
INDEXATION OF LEFT VENTRICULAR MASS, PREVALENCE OF LEFT VENTRICULAR HYPERTROPHY AND PREDICTIVE ROLE OF BLOOD PRESSURE: P1.260 (2004) (0)
Modern combination therapy: the way forward in the management of hypertensive patients. Proceedings of an international symposium. Barcelona, Spain, 1-2 November 1996. (1997) (0)
Effects of Cold Pressor Test and Diving on Systemic and Coronary Hemodynamics in 19 Subjects Cold pressor test Diving Baseline A Baseline A MAP (2005) (0)
Genome wide association study of blood pressure extremes identifies variant in uromodulin gene associated with hypertension (2010) (0)
Prognostic, diagnostic, and therapeutic advances in hypertension. (2016) (0)
RESIDUAL RISK AND RESISTANCE TO THE BENEFITS OF ANTIHYPERTENSIVE TREATMENT (2014) (0)
Address on the Occasion of the Official Dinner at the Eighth Meeting of the International Society of Hypertension by the Chairman of the Organizing Committee (1981) (0)
[Variations of the time of alveolar air formation and alveolar ventilation during respiration against inspiratory and expiratory resistance]. (1953) (0)
Abstract 19454: Identification of Upregulated microRNAs In the Plasma of Patients with Acute Myocardial Infarction (2010) (0)
[Composition of alveolar air during respiration against inspiratory and expiratory resistance]. (1952) (0)
[Carotid baroreceptor reflex in normotensive subjects and hypertensive patients]. (1976) (0)
Subject Index, Vol. 81, 1992 (1992) (0)
B017: The valsartan antihypertensive longterm use evaluation (VALUE) trial: Final patients demographics (2000) (0)
ANATOMY Remarks On Methods (1957) (0)
BENEFITS AND RISKS OF LOW-DOSE ASPIRIN IN DIFFERENT GROUPS OF HYPERTENSIVE PATIENTS IN THE HOT STUDY: P2.13 (2000) (0)
[Functional aspects of respiratory pathology. IV. Anoxia]. (1957) (0)
Benefits and Risks of Antihypertensive Treatment: How Far Can Diastolic Blood Pressure Be Lowered? (2018) (0)
Contents Vol. 81, 1992 (1992) (0)
How can the benefits of antihypertensive treatment be evaluated? (2016) (0)
Expression of concern (2018) (0)
Effect of acute and chronic administration of verapamil on cardiac structure and function in essential hypertension without left ventricular hypertrophy. (1991) (0)
[Cardiovascular effects of emotional behavior: different responses to various emotional stimuli]. (1971) (0)
49 Renal responses to atrial natriuretic factor are influenced by renal nerves (1988) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Alberto Zanchetti?

Alberto Zanchetti is affiliated with the following schools:

Alberto Zanchetti's Academic­Influence.com Rankings

Why Is Alberto Zanchetti Influential?

Alberto Zanchetti's Published Works

Published Works

What Schools Are Affiliated With Alberto Zanchetti?

Alberto Zanchetti's AcademicInfluence.com Rankings